| Year |
Citation |
Score |
| Low-probability matches (unlikely to be authored by this person) |
| 2003 |
Edwards R, Xiao D, Keysers C, Földiák P, Perrett D. Color sensitivity of cells responsive to complex stimuli in the temporal cortex. Journal of Neurophysiology. 90: 1245-56. PMID 12904507 DOI: 10.1152/Jn.00524.2002 |
0.215 |
|
| 2004 |
Földiák P, Xiao D, Keysers C, Edwards R, Perrett DI. Rapid serial visual presentation for the determination of neural selectivity in area STSa. Progress in Brain Research. 144: 107-16. PMID 14650843 DOI: 10.1016/S0079-6123(03)14407-X |
0.212 |
|
| 2013 |
Oesterreich S, Edwards R, Vlad A. Progestins: pro-senescence therapy for ovarian cancer? Cell Cycle (Georgetown, Tex.). 12: 1662-3. PMID 23708445 DOI: 10.4161/Cc.25072 |
0.2 |
|
| 2019 |
Bast RC, Matulonis UA, Sood AK, Ahmed AA, Amobi AE, Balkwill FR, Wielgos-Bonvallet M, Bowtell DDL, Brenton JD, Brugge JS, Coleman RL, Draetta GF, Doberstein K, Drapkin RI, Eckert MA, ... Edwards RP, et al. Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference. Cancer. PMID 30835824 DOI: 10.1002/Cncr.32004 |
0.199 |
|
| 2017 |
Grabosch S, Tseng G, Edwards RP, Lankes HA, Moore K, Odunsi K, Vlad A, Ma T, Strange M, Brozick J, Lugade A, Omilian A, Bshara W, Stuckey AR, Walker JL, et al. Multiplex profiling identifies distinct local and systemic alterations during intraperitoneal chemotherapy for ovarian cancer: An NRG Oncology/Gynecologic Oncology Group Study. Gynecologic Oncology. PMID 28483269 DOI: 10.1016/J.Ygyno.2017.04.008 |
0.195 |
|
| 2020 |
Hartnett EG, Knight J, Radolec M, Buckanovich RJ, Edwards RP, Vlad AM. Immunotherapy Advances for Epithelial Ovarian Cancer. Cancers. 12. PMID 33322601 DOI: 10.3390/cancers12123733 |
0.193 |
|
| 2017 |
Minlikeeva AN, Freudenheim JL, Eng KH, Cannioto RA, Friel G, Szender JB, Segal B, Odunsi K, Mayor P, Diergaarde B, Zsiros E, Kelemen LE, Köbel M, Steed H, deFazio A, ... ... Edwards R, et al. History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 26: 1470-1473. PMID 28864456 DOI: 10.1158/1055-9965.Epi-17-0367 |
0.193 |
|
| 2017 |
Minlikeeva AN, Freudenheim JL, Cannioto RA, Szender JB, Eng KH, Modugno F, Ness RB, LaMonte MJ, Friel G, Segal BH, Odunsi K, Mayor P, Zsiros E, Schmalfeldt B, Klapdor R, ... ... Edwards R, et al. History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium. Cancer Causes & Control : Ccc. PMID 28293802 DOI: 10.1007/S10552-017-0867-1 |
0.188 |
|
| 2004 |
Gordon AN, Schultes BC, Gallion H, Edwards R, Whiteside TL, Cermak JM, Nicodemus CF. CA125- and tumor-specific T-cell responses correlate with prolonged survival in oregovomab-treated recurrent ovarian cancer patients. Gynecologic Oncology. 94: 340-51. PMID 15297171 DOI: 10.1016/j.ygyno.2004.04.024 |
0.187 |
|
| 2016 |
Boisen MM, Richard SD, Holtzman MP, Edwards RP, Kelley JL, Choudry MH, Bartlett D, Huang M. Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancers: is there a role? Journal of Gastrointestinal Oncology. 7: 10-7. PMID 26941980 DOI: 10.3978/j.issn.2078-6891.2015.103 |
0.183 |
|
| 2020 |
Martins FC, Couturier DL, Paterson A, Karnezis AN, Chow C, Nazeran TM, Odunsi A, Gentry-Maharaj A, Vrvilo A, Hein A, Talhouk A, Osorio A, Hartkopf AD, Brooks-Wilson A, DeFazio A, ... ... Edwards R, et al. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium. British Journal of Cancer. PMID 32555365 DOI: 10.1038/S41416-020-0900-0 |
0.183 |
|
| 2018 |
Ma J, Salamoun J, Wipf P, Edwards R, Van Houten B, Qian W. Combination of a thioxodihydroquinazolinone with cisplatin eliminates ovarian cancer stem cell-like cells (CSC-LCs) and shows preclinical potential. Oncotarget. 9: 6042-6054. PMID 29464053 DOI: 10.18632/Oncotarget.23679 |
0.181 |
|
| 2011 |
Obermajer N, Muthuswamy R, Odunsi K, Edwards RP, Kalinski P. PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment. Cancer Research. 71: 7463-70. PMID 22025564 DOI: 10.1158/0008-5472.Can-11-2449 |
0.181 |
|
| 2017 |
Chen KS, Berhane H, Gill BS, Olawaiye A, Sukumvanich P, Kelley JL, Boisen MM, Courtney-Brooks M, Comerci JT, Edwards R, Berger J, Beriwal S. Outcomes of stage II endometrial cancer: The UPMC Hillman Cancer Center experience. Gynecologic Oncology. PMID 28866431 DOI: 10.1016/J.Ygyno.2017.08.021 |
0.181 |
|
| 2018 |
Ross MS, Burriss ME, Winger DG, Edwards RP, Courtney-Brooks M, Boisen MM. Unplanned postoperative intensive care unit admission for ovarian cancer cytoreduction is associated with significant decrease in overall survival. Gynecologic Oncology. PMID 29929924 DOI: 10.1016/j.ygyno.2018.06.008 |
0.181 |
|
| 2013 |
Suryawanshi S, Huang X, Budiu R, Mantia G, Edwards R, Vlad A. Abstract B71: Immune mechanisms that drive early carcinogenesis in endometriosis-associated ovarian cancer Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-B71 |
0.178 |
|
| 2014 |
Dalton HJ, Fiorica JV, Edwards RP, Benjamin I, Rocconi RP, Recio FO, Lovecchio JL, Burrell MO, Shahin MS, Grendys EC, Wang D, Wang T, Monk BJ. In vitro chemoresponse in metachronous pairs of ovarian cancers. Anticancer Research. 34: 7191-6. PMID 25503148 |
0.177 |
|
| 2020 |
Glubb DM, Thompson DJ, Aben KK, Alsulimani A, Amant F, Annibali D, Attia J, Barricarte A, Beckmann MW, Berchuck A, Bermisheva M, Bernardini MQ, Bischof K, Bjørge L, Bodelon C, ... ... Edwards RP, et al. Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 33144283 DOI: 10.1158/1055-9965.EPI-20-0739 |
0.177 |
|
| 2019 |
Jazaeri AA, Zsiros E, Amaria RN, Artz AS, Edwards RP, Wenham RM, Slomovitz BM, Walther A, Thomas SS, Chesney JA, Morris R, Matsuo K, Gaillard S, Rose PG, Donas JG, et al. Safety and efficacy of adoptive cell transfer using autologous tumor infiltrating lymphocytes (LN-145) for treatment of recurrent, metastatic, or persistent cervical carcinoma. Journal of Clinical Oncology. 37: 2538-2538. DOI: 10.1200/JCO.2019.37.15_SUPPL.2538 |
0.176 |
|
| 2011 |
Mantia-Smaldone GM, Edwards RP, Vlad AM. Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies. Cancer Management and Research. 3: 25-38. PMID 21734812 DOI: 10.2147/Cmr.S8759 |
0.176 |
|
| 2013 |
Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC, Köbel M, Ziogas A, Zheng W, Yang HP, ... ... Edwards R, et al. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nature Communications. 4: 1628. PMID 23535649 DOI: 10.1038/Ncomms2629 |
0.175 |
|
| 2015 |
Freese KE, Kokai L, Edwards RP, Philips BJ, Sheikh MA, Kelley J, Comerci J, Marra KG, Rubin JP, Linkov F. Adipose-derived stems cells and their role in human cancer development, growth, progression, and metastasis: a systematic review. Cancer Research. 75: 1161-8. PMID 25736688 DOI: 10.1158/0008-5472.Can-14-2744 |
0.175 |
|
| 2013 |
Rutherford T, Orr J, Grendys E, Edwards R, Krivak TC, Holloway R, Moore RG, Puls L, Tillmanns T, Schink JC, Brower SL, Tian C, Herzog TJ. A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian cancer. Gynecologic Oncology. 131: 362-7. PMID 23954900 DOI: 10.1016/j.ygyno.2013.08.009 |
0.174 |
|
| 2011 |
Obermajer N, Muthuswamy R, Lesnock J, Edwards RP, Kalinski P. Abstract LB-250: Establishment of a positive feedback between PGE2 and COX2 diverts DC differentiation into MDSCs and sustains their immunosuppressive functions in ovarian cancer Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-250 |
0.174 |
|
| 2019 |
Taylor SE, Petschauer JS, Donovan H, Schorzman A, Razo J, Zamboni WC, Edwards RP, Zorn KK. Phase I study of intravenous oxaliplatin and intraperitoneal docetaxel in recurrent ovarian cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 29: 147-152. PMID 30640697 DOI: 10.1136/Ijgc-2018-000055 |
0.173 |
|
| 2018 |
Jazaeri A, Edwards R, Wenham R, Matsuo K, Fleming GF, O'Malley DM, Slomovitz B, Monk B, Brown RJ, Suzuki S, Gorbatchevsky I, Fardis M, Zsiros E. Abstract CT172: A phase 2 multicenter study to evaluate the efficacy and safety using autologous tumor infiltrating lymphocytes (LN-145) in patients with recurrent metastatic or persistent cervical carcinoma Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Ct172 |
0.173 |
|
| 2010 |
Budiu RA, Mantia-Smaldone GM, Brozick J, Edwards RP, Vlad AM. Abstract 4793: MUC1 immunogenicity in a triple transgenic mouse model for epithelial ovarian cancer Cancer Research. 70: 4793-4793. DOI: 10.1158/1538-7445.Am10-4793 |
0.173 |
|
| 2017 |
Dixon SC, Nagle CM, Wentzensen N, Trabert B, Beeghly-Fadiel A, Schildkraut JM, Moysich KB, deFazio A, Risch HA, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, ... ... Edwards RP, et al. Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium. British Journal of Cancer. PMID 28350790 DOI: 10.1038/Bjc.2017.68 |
0.173 |
|
| 2010 |
Vlad AM, Budiu RA, Lenzner DE, Wang Y, Thaller JA, Colonello K, Crowley-Nowick PA, Kelley JL, Price FV, Edwards RP. A phase II trial of intraperitoneal interleukin-2 in patients with platinum-resistant or platinum-refractory ovarian cancer. Cancer Immunology, Immunotherapy : Cii. 59: 293-301. PMID 19690855 DOI: 10.1007/S00262-009-0750-3 |
0.172 |
|
| 2013 |
Taylor S, Beck T, Krivak T, Zorn K, Kelley J, Edwards R. Successful oxaliplatin salvage for recurrent ovarian cancer after carboplatin/cisplatin allergy Gynecologic Oncology. 130. DOI: 10.1016/J.Ygyno.2013.04.354 |
0.172 |
|
| 2018 |
Orr B, Edwards RP. Diagnosis and Treatment of Ovarian Cancer. Hematology/Oncology Clinics of North America. 32: 943-964. PMID 30390767 DOI: 10.1016/j.hoc.2018.07.010 |
0.172 |
|
| 2014 |
Berek JS, Edwards RP, Parker LP, DeMars LR, Herzog TJ, Lentz SS, Morris RT, Akerley WL, Holloway RW, Method MW, Plaxe SC, Walker JL, Friccius-Quecke H, Krasner CN. Catumaxomab for the treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: a phase II study. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 24: 1583-9. PMID 25254563 DOI: 10.1097/IGC.0000000000000286 |
0.172 |
|
| 2016 |
Cannioto RA, LaMonte MJ, Kelemen LE, Risch HA, Eng KH, Minlikeeva AN, Hong CC, Szender JB, Sucheston-Campbell L, Joseph JM, Berchuck A, Chang-Claude J, Cramer DW, DeFazio A, Diergaarde B, ... ... Edwards RP, et al. Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium. British Journal of Cancer. PMID 27299959 DOI: 10.1038/Bjc.2016.153 |
0.172 |
|
| 2018 |
Cillo AR, Bruno T, Modugno F, Edwards R, Vignali D. Abstract A23: Neuropilin-1 expression on regulatory T cells in ovarian cancer Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Ovca17-A23 |
0.172 |
|
| 2018 |
Minlikeeva AN, Moysich KB, Mayor PC, Etter JL, Cannioto RA, Ness RB, Starbuck K, Edwards RP, Segal BH, Lele S, Odunsi K, Diergaarde B, Modugno F. Anthropometric characteristics and ovarian cancer risk and survival. Cancer Causes & Control : Ccc. PMID 29327114 DOI: 10.1007/S10552-017-0997-5 |
0.172 |
|
| 2007 |
Lenzi R, Edwards R, June C, Seiden MV, Garcia ME, Rosenblum M, Freedman RS. Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma. Journal of Translational Medicine. 5: 66. PMID 18076766 DOI: 10.1186/1479-5876-5-66 |
0.171 |
|
| 2019 |
Taylor SE, Chu T, Elvin JA, Edwards RP, Zorn KK. Phase II study of everolimus and bevacizumab in recurrent ovarian, peritoneal, and fallopian tube cancer. Gynecologic Oncology. PMID 31739991 DOI: 10.1016/j.ygyno.2019.10.029 |
0.171 |
|
| 2017 |
Creasman WT, Ali S, Mutch DG, Zaino RJ, Powell MA, Mannel RS, Backes FJ, DiSilvestro PA, Argenta PA, Pearl ML, Lele SB, Guntupalli SR, Waggoner S, Spirtos N, Boggess JF, ... Edwards RP, et al. Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol. Gynecologic Oncology. PMID 28392124 DOI: 10.1016/j.ygyno.2017.03.017 |
0.171 |
|
| 2016 |
Cannioto RA, Sucheston-Campbell LE, Hampras S, Goode EL, Knutson K, Ness R, Modugno F, Wallace PK, Szender JB, Mayor P, Hong CC, Joseph JM, Friel G, Davis W, Nesline M, ... ... Edwards RP, et al. The Association of Peripheral Blood Regulatory T-Cell Concentrations With Epithelial Ovarian Cancer: A Brief Report. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 27759594 DOI: 10.1097/Igc.0000000000000845 |
0.171 |
|
| 2012 |
Modugno F, Edwards RP. Ovarian cancer: Prevention, detection, and treatment of the disease and its recurrence. Molecular mechanisms and personalized medicine meeting report International Journal of Gynecological Cancer. 22. PMID 23013733 DOI: 10.1097/IGC.0b013e31826bd1f2 |
0.17 |
|
| 2014 |
Taylor SE, Beck TL, Krivak TC, Zorn KK, Kelley JL, Edwards RP. Oxaliplatin salvage for recurrent ovarian cancer: a single institution's experience in patient populations with platinum resistant disease or a history of platinum hypersensitivity. Gynecologic Oncology. 134: 68-72. PMID 24769036 DOI: 10.1016/j.ygyno.2014.04.039 |
0.17 |
|
| 2015 |
Gau DM, Lesnock JL, Hood BL, Bhargava R, Sun M, Darcy K, Luthra S, Chandran U, Conrads TP, Edwards RP, Kelley JL, Krivak TC, Roy P. BRCA1 deficiency in ovarian cancer is associated with alteration in expression of several key regulators of cell motility - A proteomics study. Cell Cycle (Georgetown, Tex.). 14: 1884-92. PMID 25927284 DOI: 10.1080/15384101.2015.1036203 |
0.169 |
|
| 2014 |
Suryawanshi S, Huang X, Elishaev E, Budiu RA, Zhang L, Kim S, Donnellan N, Mantia-Smaldone G, Ma T, Tseng G, Lee T, Mansuria S, Edwards RP, Vlad AM. Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 6163-74. PMID 25294912 DOI: 10.1158/1078-0432.Ccr-14-1338 |
0.169 |
|
| 2010 |
Lesnock JL, Richard SD, Zorn KK, Krivak TC, Beriwal S, Sukumvanich P, McBee WC, Kelley JL, Edwards RP. Completion of intraperitoneal chemotherapy in advanced ovarian cancer and catheter-related complications. Gynecologic Oncology. 116: 345-50. PMID 19959211 DOI: 10.1016/j.ygyno.2009.11.009 |
0.169 |
|
| 2005 |
Peters DG, Kudla DM, Deloia JA, Chu TJ, Fairfull L, Edwards RP, Ferrell RE. Comparative gene expression analysis of ovarian carcinoma and normal ovarian epithelium by serial analysis of gene expression. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 1717-23. PMID 16030107 DOI: 10.1158/1055-9965.Epi-04-0704 |
0.169 |
|
| 2017 |
Magge D, Ramalingam L, Shuai Y, Edwards RP, Pingpank JF, Ahrendt SS, Holtzman MP, Zeh HJ, Bartlett DL, Choudry HA. Hyperthermic intraperitoneal chemoperfusion as a component of multimodality therapy for ovarian and primary peritoneal cancer. Journal of Surgical Oncology. PMID 28628712 DOI: 10.1002/jso.24666 |
0.168 |
|
| 2013 |
Hadorn D, Wilson N, Edwards R, Blakely T, Sarfati D. How to substantially increase recruitment in cancer trials in New Zealand. The New Zealand Medical Journal. 126: 57-68. PMID 24150266 |
0.168 |
|
| 2015 |
Boisen M, Richard S, Edwards R, Kelley J, Huang M. Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancers: Is there a role? Gynecologic Oncology. 137: 184. DOI: 10.1016/J.YGYNO.2015.01.461 |
0.168 |
|
| 2019 |
Modugno F, Goughnour SL, Wallack D, Edwards RP, Odunsi K, Kelley JL, Moysich K, Ness RB, Brooks MM. Breastfeeding factors and risk of epithelial ovarian cancer. Gynecologic Oncology. PMID 30686553 DOI: 10.1016/J.Ygyno.2019.01.017 |
0.168 |
|
| 2005 |
Helm CW, Martin R, Metzinger DS, Edwards RP. Secondary surgical cytoreduction and hyperthermic intraperitoneal chemotherapy: A novel treatment for recurrent endometrial cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 5181. PMID 27946776 DOI: 10.1200/jco.2005.23.16_suppl.5181 |
0.168 |
|
| 2015 |
Jim HS, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Chen Z, Chen AY, Permuth-Wey J, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, ... ... Edwards RP, et al. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC). Journal of Genetics and Genome Research. 2. PMID 26807442 |
0.167 |
|
| 2017 |
Minlikeeva AN, Freudenheim JL, Cannioto RA, Eng KH, Szender JB, Mayor P, Etter JL, Cramer DW, Diergaarde B, Doherty JA, Dörk T, Edwards R, deFazio A, Friel G, Goodman MT, et al. History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report. British Journal of Cancer. PMID 28817835 DOI: 10.1038/Bjc.2017.267 |
0.167 |
|
| 2012 |
Skaznik-Wikiel ME, Lesnock JL, McBee WC, Beriwal S, Zorn KK, Richard SD, Krivak TC, Edwards RP. Intraperitoneal chemotherapy for recurrent epithelial ovarian cancer is feasible with high completion rates, low complications, and acceptable patient outcomes International Journal of Gynecological Cancer. 22: 232-237. PMID 22080886 DOI: 10.1097/IGC.0b013e318234f833 |
0.166 |
|
| 2012 |
Kurta ML, Moysich KB, Weissfeld JL, Youk AO, Bunker CH, Edwards RP, Modugno F, Ness RB, Diergaarde B. Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1282-92. PMID 22707710 DOI: 10.1158/1055-9965.Epi-12-0426 |
0.165 |
|
| 2021 |
Fu Z, Kelley JL, Odunsi K, Edwards RP, Moysich K, Modugno F. Gestational weight gain and risk of epithelial ovarian cancer. Cancer Causes & Control : Ccc. PMID 33616777 DOI: 10.1007/s10552-021-01405-5 |
0.165 |
|
| 2019 |
Minlikeeva AN, Cannioto R, Jensen A, Kjaer SK, Jordan SJ, Diergaarde B, Szender JB, Odunsi K, Almohanna H, Mayor P, Starbuck K, Zsiros E, Bandera EV, Cramer DW, Doherty JA, ... ... Edwards R, et al. Joint exposure to smoking, excessive weight, and physical inactivity and survival of ovarian cancer patients, evidence from the Ovarian Cancer Association Consortium. Cancer Causes & Control : Ccc. PMID 30905014 DOI: 10.1007/S10552-019-01157-3 |
0.165 |
|
| 2016 |
Rasmussen CB, Kjaer SK, Albieri V, Bandera EV, Doherty JA, Høgdall E, Webb PM, Jordan SJ, Rossing MA, Wicklund KG, Goodman MT, Modugno F, Moysich KB, Ness RB, Edwards RP, et al. Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies. American Journal of Epidemiology. PMID 27941069 DOI: 10.1093/Aje/Kww161 |
0.164 |
|
| 2010 |
Helm CW, Richard SD, Pan J, Bartlett D, Goodman MD, Hoefer R, Lentz SS, Levine EA, Loggie BW, Metzinger DS, Miller B, Parker L, Spellman JE, Sugarbaker PH, Edwards RP, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER-O registry. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 20: 61-9. PMID 20130504 DOI: 10.1111/IGC.0b013e3181c50cde |
0.164 |
|
| 2015 |
Lu Y, Cuellar G, Painter JN, Nyholt D, Morris AP, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, ... ... Edwards RP, et al. Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. Human Molecular Genetics. PMID 26231222 DOI: 10.1093/Hmg/Ddv306 |
0.164 |
|
| 2016 |
Orr B, Edwards R, Lin J, Kelley J, Olawaiye A, Beriwal S, Comerci J, Huang M, Courtney-Brooks M, Sukumvanich P. Comparison of treatment and survival between carcinosarcoma and serous epithelial ovarian cancer Gynecologic Oncology. 141: 202-203. DOI: 10.1016/J.YGYNO.2016.04.522 |
0.163 |
|
| 2014 |
Taylor SE, Li R, Petschauer JS, Donovan H, Zamboni WC, Edwards RP, Zorn KK. Abstract CT412: Phase I study of intraveneous docetaxel and intraperitoneal oxaliplatin in recurrent ovarian, fallopian tube and peritoneal cancer Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Ct412 |
0.163 |
|
| 2020 |
Adambekov S, Lopa S, Edwards RP, Lemon L, Wang S, Taylor SE, Orr B, Linkov F. Survival and recurrence after intraperitoneal chemotherapy use: Retrospective review of ovarian cancer hospital registrydata. Cancer Medicine. PMID 32813321 DOI: 10.1002/Cam4.3340 |
0.163 |
|
| 2015 |
Boisen M, Berger J, Phillips J, Taylor S, Peters A, Comerci J, Edwards R, Kelley J, Sukumvanich P, Huang M. Time to chemotherapy following surgical cytoreduction for epithelial ovarian cancer: Does neoadjuvant chemotherapy make a difference? Gynecologic Oncology. 137: 118. DOI: 10.1016/J.YGYNO.2015.01.293 |
0.163 |
|
| 2014 |
Charbonneau B, Block MS, Bamlet WR, Vierkant RA, Kalli KR, Fogarty Z, Rider DN, Sellers TA, Tworoger SS, Poole E, Risch HA, Salvesen HB, Kiemeney LA, Baglietto L, Giles GG, ... ... Edwards R, et al. Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Research. 74: 852-61. PMID 24272484 DOI: 10.1158/0008-5472.Can-13-1051 |
0.162 |
|
| 2010 |
Phelan CM, Tsai YY, Goode EL, Vierkant RA, Fridley BL, Beesley J, Chen XQ, Webb PM, Chanock S, Cramer DW, Moysich K, Edwards RP, Chang-Claude J, Garcia-Closas M, Yang H, et al. Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 600-4. PMID 20142253 DOI: 10.1158/1055-9965.Epi-09-0861 |
0.162 |
|
| 2008 |
Beriwal S, Heron DE, Mogus R, Edwards RP, Kelley JL, Sukumvanich P. High-dose rate brachytherapy (HDRB) for primary or recurrent cancer in the vagina. Radiation Oncology (London, England). 3: 7. PMID 18271958 DOI: 10.1186/1748-717X-3-7 |
0.162 |
|
| 2018 |
Dohopolski MJ, Horne ZD, Gebhardt BJ, Glaser SM, Edwards RP, Kelley JL, Comerci JT, Olawaiye AB, Courtney-Brooks M, Berger JL, Sukumvanich P, Beriwal S. Single-institutional outcomes of adjuvant brachytherapy for Stage I endometrial cancer-Are outcomes consistent with randomized studies? Brachytherapy. PMID 29426745 DOI: 10.1016/j.brachy.2018.01.004 |
0.162 |
|
| 2016 |
Winham SJ, Pirie A, Chen YA, Larson MC, Fogarty ZC, Earp MA, Anton-Culver H, Bandera EV, Cramer D, Doherty JA, Goodman MT, Gronwald J, Karlan BY, Kjaer SK, Levine DA, ... ... Edwards RP, et al. Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 25: 446-54. PMID 26747452 DOI: 10.1158/1055-9965.EPI-15-0240 |
0.162 |
|
| 2016 |
Dixon SC, Nagle CM, Thrift AP, Pharoah PD, Pearce CL, Zheng W, Painter JN, Chenevix-Trench AG, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, Rossing MA, ... ... Edwards RP, et al. Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. International Journal of Epidemiology. PMID 27401727 DOI: 10.1093/Ije/Dyw158 |
0.162 |
|
| 2018 |
Dixon-Suen SC, Nagle CM, Thrift AP, Pharoah PDP, Ewing A, Pearce CL, Zheng W, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, ... ... Edwards RP, et al. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. British Journal of Cancer. PMID 29555990 DOI: 10.1038/S41416-018-0011-3 |
0.161 |
|
| 2012 |
Rowland M, Lesnock J, Edwards R, Richard S, Zorn K, Sukumvanich P, Krivak T. Occult uterine cancer in patients undergoing laparoscopic hysterectomy with morcellation Gynecologic Oncology. 127. DOI: 10.1016/J.Ygyno.2012.07.080 |
0.161 |
|
| 2011 |
Skaznik-Wikiel M, Lesnock J, McBee W, Taylor S, Beriwal S, Smith A, Zorn K, Richard S, Krivak T, Edwards R. Intraperitoneal chemotherapy for recurrent ovarian cancer appears efficacious with high completion rates and low complications Gynecologic Oncology. 120. DOI: 10.1016/J.Ygyno.2010.12.074 |
0.161 |
|
| 2003 |
Makhija S, Sit A, Edwards R, Aufman K, Weiss H, Kanbour-Shakir A, Gooding W, D'Angelo G, Ferrell R, Raja S, Godfrey TE. Identification of genetic alterations related to chemoresistance in epithelial ovarian cancer Gynecologic Oncology. 90: 3-9. PMID 12821334 DOI: 10.1016/S0090-8258(03)00177-X |
0.161 |
|
| 2005 |
Heron DE, Axtel A, Gerszten K, Amortegui A, Kelley J, Comerci J, Edwards RP. Villoglandular adenocarcinoma of the cervix recurrent in an episiotomy scar: a case report in a 32-year-old female International Journal of Gynecologic Cancer. 15: 366-371. DOI: 10.1136/ijgc-00009577-200503000-00030 |
0.161 |
|
| 2013 |
Halligan S, Wooldrage K, Dadswell E, Kralj-Hans I, von Wagner C, Edwards R, Yao G, Kay C, Burling D, Faiz O, Teare J, Lilford RJ, Morton D, Wardle J, Atkin W, et al. Computed tomographic colonography versus barium enema for diagnosis of colorectal cancer or large polyps in symptomatic patients (SIGGAR): a multicentre randomised trial. Lancet. 381: 1185-93. PMID 23414648 DOI: 10.1016/S0140-6736(12)62124-2 |
0.161 |
|
| 2005 |
Heron DE, Axtel A, Gerszten K, Amortegui A, Kelley J, Comerci J, Edwards RP. Villoglandular adenocarcinoma of the cervix recurrent in an episiotomy scar: A case report in a 32-year-old female International Journal of Gynecological Cancer. 15: 366-371. PMID 15823127 DOI: 10.1111/j.1525-1438.2005.15231.x |
0.161 |
|
| 2015 |
Taylor SE, Li R, Petschauer JS, Donovan HD, Zamboni WC, Edwards RP, Zorn KK. Phase I study of intravenous (IV) oxaliplatin and intraperitoneal (IP) docetaxel in recurrent ovarian and primary peritoneal cancer Gynecologic Oncology. 137: 148. DOI: 10.1016/J.Ygyno.2015.01.370 |
0.16 |
|
| 2014 |
Kurta M, Edwards R, Moysich K, McDonough K, Bertolet M, Weissfeld J, Catov J, Modugno F, Bunker C, Ness R, Diergaarde B. Abstract LB-273: Prognosis and conditional disease-free survival among ovarian cancer patients Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-273 |
0.159 |
|
| 2015 |
Edwards RP, Huang X, Vlad AM. Chronic inflammation in endometriosis and endometriosis-associated ovarian cancer: New roles for the "old" complement pathway. Oncoimmunology. 4: e1002732. PMID 26155393 DOI: 10.1080/2162402X.2014.1002732 |
0.159 |
|
| 2019 |
Iheagwara UK, Vargo JA, Chen KS, Burton D, Taylor SE, Berger JL, Boisen MM, Comerci JT, Orr B, Sukumvanich P, Olawaiye AB, Kelley JL, Edwards RP, Courtney-Brooks M, Beriwal S. Neoadjuvant Chemoradiotherapy Followed by Extrafascial Hysterectomy in Locally Advanced Type II Endometrial Cancer Clinically Extending to Cervix. Practical Radiation Oncology. PMID 30802615 DOI: 10.1016/J.Prro.2019.02.007 |
0.159 |
|
| 2011 |
Budiu RA, Mantia-Smaldone G, Elishaev E, Chu T, Thaller J, McCabe K, Lenzner D, Edwards RP, Vlad AM. Soluble MUC1 and serum MUC1-specific antibodies are potential prognostic biomarkers for platinum-resistant ovarian cancer. Cancer Immunology, Immunotherapy : Cii. 60: 975-84. PMID 21461842 DOI: 10.1007/S00262-011-1010-X |
0.158 |
|
| 2016 |
Præstegaard C, Kjaer SK, Nielsen TS, Jensen SM, Webb PM, Nagle CM, Høgdall E, Risch HA, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Moysich K, Ness RB, ... Edwards RP, et al. The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies. Cancer Epidemiology. 41: 71-79. PMID 26851750 DOI: 10.1016/J.Canep.2016.01.012 |
0.158 |
|
| 2011 |
Zamboni WC, Combest AJ, DeLoia JA, Edwards RP, Bridges AS, Zamboni BA, Walko CM, Yu AY, Krivak TC, Kelley JL. Pharmacologic and phenotypic study of docetaxel in patients with ovarian or primary peritoneal cancer. Cancer Chemotherapy and Pharmacology. 68: 1255-62. PMID 21437702 DOI: 10.1007/S00280-011-1609-9 |
0.158 |
|
| 2020 |
Stenzel AE, Abrams SI, Joseph JM, Goode EL, Tario JD, Wallace PK, Kaur D, Adamson AK, Buas MF, Lugade AA, Laslavic A, Taylor SE, Orr B, Edwards RP, Elishaev E, et al. Circulating CD14 HLA-DR monocytic cells as a biomarker for epithelial ovarian cancer progression. American Journal of Reproductive Immunology (New York, N.Y. : 1989). e13343. PMID 32905653 DOI: 10.1111/Aji.13343 |
0.157 |
|
| 2019 |
Cillo AR, Chuckran CA, Liao M, Modugno F, Edwards R, Coffman L, Vignali DAA, Bruno TC. Abstract TMIM-063: TARGETING NEUROPILIN-1+ T REGULATORY CELLS IN PATIENTS WITH HIGH GRADE SEROUS OVARIAN CANCER DECREASES TREG-SPECIFIC SUPPRESSION OF CD8+ T CELLS Clinical Cancer Research. 25. DOI: 10.1158/1557-3265.Ovcasymp18-Tmim-063 |
0.157 |
|
| 2016 |
Cannioto R, LaMonte MJ, Risch HA, Hong CC, Sucheston-Campbell LE, Eng KH, Szender JB, Chang-Claude J, Schmalfeldt B, Klapdor R, Gower E, Minlikeeva AN, Zirpoli GR, Bandera EV, Berchuck A, ... ... Edwards RP, et al. Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27197285 DOI: 10.1158/1055-9965.Epi-15-1330 |
0.155 |
|
| 2014 |
Vargo JA, Boisen MM, Comerci JT, Kim H, Houser CJ, Sukumvanich P, Olawaiye AB, Kelley JL, Edwards RP, Huang M, Courtney-Brooks M, Beriwal S. Neoadjuvant radiotherapy with or without chemotherapy followed by extrafascial hysterectomy for locally advanced endometrial cancer clinically extending to the cervix or parametria. Gynecologic Oncology. 135: 190-5. PMID 25218303 DOI: 10.1016/j.ygyno.2014.09.001 |
0.155 |
|
| 2004 |
Taylor DD, Edwards RP, Case CR, Gerçel-Taylor C. Modulation of CD3-zeta as a marker of clinical response to IL-2 therapy in ovarian cancer patients Gynecologic Oncology. 94: 54-60. PMID 15262119 DOI: 10.1016/j.ygyno.2004.03.032 |
0.155 |
|
| 2009 |
Naumann RW, Sukumvanich P, Edwards RP. Practice patterns of intraperitoneal chemotherapy in women with ovarian cancer Gynecologic Oncology. 114: 37-41. PMID 19410281 DOI: 10.1016/j.ygyno.2009.04.001 |
0.155 |
|
| 2012 |
Odunsi K, Matsuzaki J, Karbach J, Neumann A, Mhawech-Fauceglia P, Miller A, Beck A, Morrison CD, Ritter G, Godoy H, Lele S, DuPont N, Edwards R, Shrikant P, Old LJ, et al. Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients Proceedings of the National Academy of Sciences of the United States of America. 109: 5797-5802. PMID 22454499 DOI: 10.1073/Pnas.1117208109 |
0.155 |
|
| 2015 |
Yu MC, Austin RM, Lin J, Beck T, Beriwal S, Comerci JT, Edwards RP, Sukumvanich P, Kelley J, Olawaiye AB. The Role of High-Risk Human Papilloma Virus Testing in the Surveillance of Cervical Cancer After Treatment. Archives of Pathology & Laboratory Medicine. 139: 1437-40. PMID 26516940 DOI: 10.5858/arpa.2014-0534-OA |
0.154 |
|
| 2015 |
Edwards RP. The Legacy of Intraperitoneal Therapy in Ovarian Cancer: Why Are We Never Satisfied With the Answer. Oncology (Williston Park, N.Y.). 29: 705-6. PMID 26384809 |
0.153 |
|
| 2011 |
Skaznik-Wikiel ME, Lesnock JL, McBee WC, Richard SD, Kelley JL, Zorn KK, Krivak TC, Edwards RP. Extended duration of response with second-line intraperitoneal platinum-based therapy for epithelial ovarian cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 5073. PMID 28023668 DOI: 10.1200/jco.2011.29.15_suppl.5073 |
0.153 |
|
| 2014 |
Kurta ML, Edwards RP, Moysich KB, McDonough K, Bertolet M, Weissfeld JL, Catov JM, Modugno F, Bunker CH, Ness RB, Diergaarde B. Prognosis and conditional disease-free survival among patients with ovarian cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 4102-12. PMID 25403208 DOI: 10.1200/Jco.2014.55.1713 |
0.153 |
|
| 2011 |
Berek JS, Edwards RP, Parker L, DeMars LR, Herzog TJ, Lentz SS, Morris R, Akerley WL, Holloway RW, Method M, Plaxe SC, Walker JL, Schindler T, Schulze E, Krasner CN, et al. Catumaxomab treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: A phase II study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 5048. PMID 28023703 DOI: 10.1200/jco.2011.29.15_suppl.5048 |
0.153 |
|
| 2015 |
Qian W, Wang J, Edwards R, Wipf P, Houten BV. Abstract POSTER-THER-1425: Novel small molecules overcoming platinum drug resistance in ovarian cancer cells Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Ovcasymp14-Poster-Ther-1425 |
0.153 |
|
| 2016 |
Hampras SS, Sucheston-Campbell LE, Cannioto R, Chang-Claude J, Modugno F, Dörk T, Hillemanns P, Preus L, Knutson KL, Wallace PK, Hong CC, Friel G, Davis W, Nesline M, Pearce CL, ... ... Edwards RP, et al. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. Oncotarget. PMID 27533245 DOI: 10.18632/Oncotarget.10215 |
0.153 |
|
| 2013 |
Russell IT, Edwards RT, Gliddon AE, Ingledew DK, Russell D, Whitaker R, Yeo ST, Attwood SE, Barr H, Nanthakumaran S, Park KG. Cancer of Oesophagus or Gastricus - New Assessment of Technology of Endosonography (COGNATE): report of pragmatic randomised trial. Health Technology Assessment (Winchester, England). 17: 1-170. PMID 24034150 DOI: 10.3310/hta17390 |
0.153 |
|
| 2013 |
Suryawanshi S, Vlad AM, Lin HM, Mantia-Smaldone G, Laskey R, Lee M, Lin Y, Donnellan N, Klein-Patel M, Lee T, Mansuria S, Elishaev E, Budiu R, Edwards RP, Huang X. Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 1213-24. PMID 23362326 DOI: 10.1158/1078-0432.Ccr-12-2726 |
0.153 |
|
| 2015 |
Lin JF, Muñiz K, Sukumvanich P, Gehrig P, Beriwal S, Kelley JL, Edwards RP, Olawaiye AB. Survival advantage associated with multimodal therapy in women with node-positive (stage-IIIC) uterine papillary serous carcinoma: a National Cancer Database study. Bjog : An International Journal of Obstetrics and Gynaecology. PMID 26537059 DOI: 10.1111/1471-0528.13726 |
0.153 |
|
| 2018 |
Grabosch S, Bulatovic M, Zeng F, Ma T, Zhang L, Ross M, Brozick J, Tseng G, Elishaev E, Edwards RP, Vlad A. Abstract B29: Cisplatin is pro-immunogenic and promotes intrinsic and reactive immune suppression in inflamed and noninflamed ovarian cancer mouse models Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Ovca17-B29 |
0.153 |
|
| 2015 |
Boisen M, Vargo J, Beriwal S, Sukumvanich P, Olawaiye A, Kelley J, Edwards R, Huang M, Courtney-Brooks M, Comerci J. Surgical outcomes of patients undergoing extrafascial hysterectomy following neoadjuvant high-dose rate brachytherapy for locally advanced endometrial cancer clinically extending to the cervix or parametria Gynecologic Oncology. 137: 95. DOI: 10.1016/J.YGYNO.2015.01.235 |
0.152 |
|
| 2015 |
Grabosch S, Vlad AM, Ma T, Mony JT, Strange M, Brozick J, Thaller J, Tseng G, Huang X, Moore K, Odunsi K, Edwards RP. Abstract 414: Prospective profiling of systemic and loco-regional alterations during intraperitoneal chemotherapy for ovarian cancer, results from GOG 271 Cancer Research. 75: 414-414. DOI: 10.1158/1538-7445.Am2015-414 |
0.152 |
|
| 2018 |
Ross MS, Tianzhou M, Zhang L, Priedigkeit N, Tseng G, Lee AV, Edwards RP, Vlad AM. Abstract B33: Neoepitope peptide vaccines and immune checkpoint blockade in a new preclinical ovarian cancer model Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Ovca17-B33 |
0.152 |
|
| 2011 |
Hoskins ER, Hood BL, Sun M, Krivak TC, Edwards RP, Conrads TP. Proteomic analysis of ovarian cancer proximal fluids: validation of elevated peroxiredoxin 1 in patient peripheral circulation. Plos One. 6: e25056. PMID 21980378 DOI: 10.1371/Journal.Pone.0025056 |
0.152 |
|
| 2013 |
Budiu RA, Elishaev E, Brozick J, Lee M, Edwards RP, Kalinski P, Vlad AM. Immunobiology of human mucin 1 in a preclinical ovarian tumor model. Oncogene. 32: 3664-75. PMID 22964632 DOI: 10.1038/Onc.2012.397 |
0.152 |
|
| 2013 |
Atkin W, Dadswell E, Wooldrage K, Kralj-Hans I, von Wagner C, Edwards R, Yao G, Kay C, Burling D, Faiz O, Teare J, Lilford RJ, Morton D, Wardle J, Halligan S, et al. Computed tomographic colonography versus colonoscopy for investigation of patients with symptoms suggestive of colorectal cancer (SIGGAR): a multicentre randomised trial. Lancet. 381: 1194-202. PMID 23414650 DOI: 10.1016/S0140-6736(12)62186-2 |
0.152 |
|
| 2013 |
Hurt CN, Roberts K, Rogers TK, Griffiths GO, Hood K, Prout H, Nelson A, Fitzgibbon J, Barham A, Thomas-Jones E, Edwards RT, Yeo ST, Hamilton W, Tod A, Neal RD. A feasibility study examining the effect on lung cancer diagnosis of offering a chest X-ray to higher-risk patients with chest symptoms: protocol for a randomized controlled trial. Trials. 14: 405. PMID 24279296 DOI: 10.1186/1745-6215-14-405 |
0.151 |
|
| 2018 |
Ross M, Tianzhou M, Priedigkeit N, Zhang L, Tseng G, Lee A, Edwards R, Vlad A. An in vitro evaluation of neoantigens derived from gene fusion events in ovarian cancer patients Gynecologic Oncology. 149: 8. DOI: 10.1016/J.Ygyno.2018.04.025 |
0.151 |
|
| 2016 |
Earp M, Winham SJ, Larson N, Permuth JB, Sicotte H, Chien J, Anton-Culver H, Bandera EV, Berchuck A, Cook LS, Cramer D, Doherty JA, Goodman MT, Levine DA, Monteiro AN, ... ... Edwards RP, et al. A targeted genetic association study of epithelial ovarian cancer susceptibility. Oncotarget. 7: 7381-9. PMID 26848776 DOI: 10.18632/Oncotarget.7121 |
0.151 |
|
| 2018 |
Block MS, Vierkant RA, Rambau PF, Winham SJ, Wagner P, Traficante N, Tołoczko A, Tiezzi DG, Taran FA, Sinn P, Sieh W, Sharma R, Rothstein JH, Ramón Y Cajal T, Paz-Ares L, ... ... Edwards RP, et al. MyD88 and TLR4 Expression in Epithelial Ovarian Cancer. Mayo Clinic Proceedings. 93: 307-320. PMID 29502561 DOI: 10.1016/j.mayocp.2017.10.023 |
0.151 |
|
| 2008 |
Ness RB, Shen C, Bass D, Jackson C, Moysich K, Edwards R, Brunham RC. Chlamydia trachomatis serology in women with and without ovarian cancer. Infectious Diseases in Obstetrics and Gynecology. 2008: 219672. PMID 19125176 DOI: 10.1155/2008/219672 |
0.151 |
|
| 2016 |
Cannioto R, LaMonte MJ, Risch HA, Hong CC, Sucheston-Campbell LE, Eng KH, Szender JB, Chang-Claude J, Schmalfeldt B, Klapdor R, Gower E, Minlikeeva AN, Zirpoli G, Bandera EV, Berchuck A, ... ... Edwards RP, et al. Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium Obstetrical and Gynecological Survey. 71: 528-530. DOI: 10.1097/Ogx.0000000000000357 |
0.151 |
|
| 2014 |
Vargo JA, Kim H, Houser CJ, Berhane H, Sukumvanich P, Olawaiye AB, Kelley JL, Edwards RP, Comerci JT, Huang M, Courtney-Brooks M, Beriwal S. Definitive salvage for vaginal recurrence of endometrial cancer: the impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratification. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 113: 126-31. PMID 25241996 DOI: 10.1016/j.radonc.2014.08.038 |
0.149 |
|
| 2020 |
Richman AH, Vargo JA, Ling DC, Sukumvanich P, Berger JL, Boisen MM, Edwards R, Taylor SE, Courtney-Brooks MB, Olawaiye A, Orr BC, Beriwal S. Dose-escalated intensity modulated radiation therapy in patients with locally-advanced vulvar cancer - does it increase response rate? Gynecologic Oncology. PMID 32981696 DOI: 10.1016/j.ygyno.2020.09.019 |
0.149 |
|
| 2017 |
Linkov F, Goughnour SL, Edwards RP, Lokshin A, Ramanathan RC, Hamad GG, McCloskey C, Bovbjerg DH. Endometrial cancer associated biomarkers in bariatric surgery candidates: exploration of racial differences. Surgery For Obesity and Related Diseases : Official Journal of the American Society For Bariatric Surgery. PMID 28256392 DOI: 10.1016/J.Soard.2017.01.024 |
0.149 |
|
| 2018 |
Suarez Mora A, Taylor S, Olawaiye A, Beriwal S, Kelley J, Edwards R, Comerci J, Courtney-Brooks M, Boisen M, Berger J, Orr B, Sukumvanich P. Outcomes in patients who refuse initial treatment for endometrial cancer Gynecologic Oncology. 149: 213. DOI: 10.1016/J.YGYNO.2018.04.484 |
0.149 |
|
| 2013 |
Rowland M, Lesnock J, Edwards R, Richard S, Zorn K, Sukumvanich P, Krivak T. Occult uterine cancer in patients undergoing laparoscopic hysterectomy with morcellation: Implications for surveillance for disease recurrence and outcomes Gynecologic Oncology. 130. DOI: 10.1016/J.Ygyno.2013.04.243 |
0.148 |
|
| 2010 |
Monk BJ, Sill M, Walker JL, Hanjani P, Edwards RP, Rotmensch J, De Geest K, Bonebrake AJ. Activity of docetaxel plus trabectedin in recurrent or persistent ovarian and primary peritoneal cancer: A phase II study of the Gynecologic Oncology Group (GOG). Journal of Clinical Oncology. 28: 5046-5046. DOI: 10.1200/jco.2010.28.15_suppl.5046 |
0.148 |
|
| 2015 |
Mony J, Zhang L, Tirodkar T, Elishaev E, Brozick J, Edwards RP, Vlad AM. Abstract POSTER-THER-1434: Intraperitoneal anti-PD-L1 increases survival in a novel ovarian cancer model and its in vivo efficacy is influenced by baseline anti-tumor immunity of the host Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Ovcasymp14-Poster-Ther-1434 |
0.148 |
|
| 2012 |
Kannan N, Beriwal S, Kim H, Houser C, Mogus R, Sukumvanich P, Olawaiye AB, Richard S, Kelley JL, Edwards RP, Krivak TC. High-dose-rate interstitial computed tomography-based brachytherapy for the treatment of cervical cancer: early results. Brachytherapy. 11: 408-12. PMID 22513106 DOI: 10.1016/j.brachy.2012.02.007 |
0.148 |
|
| 2013 |
Faber MT, Kjær SK, Dehlendorff C, Chang-Claude J, Andersen KK, Høgdall E, Webb PM, Jordan SJ, Rossing MA, Doherty JA, Lurie G, Thompson PJ, Carney ME, ... ... Edwards RP, et al. Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies. Cancer Causes & Control : Ccc. 24: 989-1004. PMID 23456270 DOI: 10.1007/S10552-013-0174-4 |
0.148 |
|
| 2011 |
Hoskins E, Hood B, Sun M, Krivak T, Conrads T, Edwards R. Epithelial ovarian cancer tumor microenvironment is a favorable biomarker resource Gynecologic Oncology. 120. DOI: 10.1016/J.Ygyno.2010.12.118 |
0.147 |
|
| 2014 |
Linkov F, Kokai L, Edwards R, Sheikh MA, Freese KE, Marra KG, Rubin JP. The role of adipose-derived stem cells in endometrial cancer proliferation. Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum. 244: 54-8; discussion 57-. PMID 25083894 DOI: 10.3109/00365513.2014.936682 |
0.147 |
|
| 2013 |
Zabron A, Edwards RJ, Khan SA. The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer. Disease Models & Mechanisms. 6: 281-92. PMID 23520144 DOI: 10.1242/dmm.010561 |
0.147 |
|
| 2017 |
Donovan H, Wenzel L, Sereika S, Ward S, Edwards R, Penson R, Hagan T. Defining priority symptoms in recurrent ovarian cancer: A comparison of four different criteria from a Gynecologic Oncology Group study (GOG 259) Gynecologic Oncology. 145: 25. DOI: 10.1016/J.Ygyno.2017.03.072 |
0.146 |
|
| 2016 |
Wenzel LB, Ward S, Sereika SM, Edwards RP, Spring M, Bender CM, Penson RT, Hagan T. Determining priority symptoms of women with recurrent ovarian cancers: A Gynecologic Oncology Group study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34: 101. PMID 28156639 DOI: 10.1200/Jco.2016.34.26_Suppl.101 |
0.146 |
|
| 2006 |
Beriwal S, Bhatnagar A, Heron DE, Selvaraj R, Mogus R, Kim H, Gerszten K, Kelley J, Edwards RP. High-dose-rate interstitial brachytherapy for gynecologic malignancies Brachytherapy. 5: 218-222. PMID 17118313 DOI: 10.1016/j.brachy.2006.09.002 |
0.146 |
|
| 2018 |
Hay CM, Kelley JL, Edwards RP, Pombier KM, Comerci JT. Super-Utilization of Health Care Resources Among Gynecologic Oncology Patients. American Journal of Medical Quality : the Official Journal of the American College of Medical Quality. 1062860618757343. PMID 29463092 DOI: 10.1177/1062860618757343 |
0.146 |
|
| 2015 |
Vargo JA, Boisen MM, Comerci JT, Kim H, Houser CJ, Sukumvanich P, Olawaiye AB, Kelley JC, Edwards RP, Huang M, Courtney-Brooks M, Beriwal S. Neoadjuvant High-Dose-Rate Brachytherapy Followed By Extrafascial Hysterectomy for Locally Advanced Endometrial Cancer Clinically Extending to Cervix or Parametria Brachytherapy. 14: S18. DOI: 10.1016/J.BRACHY.2015.02.211 |
0.146 |
|
| 2011 |
Ness RB, Dodge RC, Edwards RP, Baker JA, Moysich KB. Contraception methods, beyond oral contraceptives and tubal ligation, and risk of ovarian cancer. Annals of Epidemiology. 21: 188-96. PMID 21109450 DOI: 10.1016/J.Annepidem.2010.10.002 |
0.146 |
|
| 2015 |
Linkov F, Edwards RP, Althouse A, Rauh-Hain JA, Del Carmen MG, Freese KE, Kelley JL, Olawaiye AB. Obesity, lymphadenectomy and survival outcomes in intermediate to high-risk, early-stage endometrial cancer patients. Future Oncology (London, England). 11: 607-15. PMID 25686116 DOI: 10.2217/Fon.14.247 |
0.145 |
|
| 2015 |
Chornokur G, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Amankwah EK, Qu X, Tsai YY, Jim HS, Chen Z, Chen AY, Permuth-Wey J, Aben KKh, Anton-Culver H, Antonenkova N, ... ... Edwards RP, et al. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. Plos One. 10: e0128106. PMID 26091520 DOI: 10.1371/Journal.Pone.0128106 |
0.145 |
|
| 2015 |
Lee AW, Tyrer JP, Doherty JA, Stram DA, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Spiewankiewicz B, Myers EJ, Chenevix-Trench G, Fasching PA, Beckmann MW, Ekici AB, ... ... Edwards RP, et al. Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study. Gynecologic Oncology. 136: 542-8. PMID 25528498 DOI: 10.1016/J.Ygyno.2014.12.017 |
0.145 |
|
| 2015 |
Halligan S, Wooldrage K, Dadswell E, Shah U, Kralj-Hans I, von Wagner C, Faiz O, Teare J, Edwards R, Kay C, Yao G, Lilford RJ, Morton D, Wardle J, Atkin W, et al. Identification of Extracolonic Pathologies by Computed Tomographic Colonography in Colorectal Cancer Symptomatic Patients. Gastroenterology. 149: 89-101.e5. PMID 25796362 DOI: 10.1053/J.Gastro.2015.03.011 |
0.145 |
|
| 2007 |
Helm CW, Randall-Whitis L, Martin RS, Metzinger DS, Gordinier ME, Parker LP, Edwards RP. Hyperthermic intraperitoneal chemotherapy in conjunction with surgery for the treatment of recurrent ovarian carcinoma Gynecologic Oncology. 105: 90-96. PMID 17173957 DOI: 10.1016/j.ygyno.2006.10.051 |
0.145 |
|
| 2016 |
Zhang M, Liu G, Xue F, Edwards R, Sood AK, Zhang W, Yang D. Copy number deletion of RAD50 as predictive marker of BRCAness and PARP inhibitor response in BRCA wild type ovarian cancer. Gynecologic Oncology. 141: 57-64. PMID 27016230 DOI: 10.1016/J.Ygyno.2016.01.004 |
0.144 |
|
| 1996 |
EDWARDS R. Characterization of tumor infiltrating lymphocytes isolated from early and advanced staged ovarian cancer. Journal of the Society For Gynecologic Investigation. 3: 380A. DOI: 10.1016/1071-5576(96)83090-5 |
0.144 |
|
| 2021 |
Keller A, Rodríguez-López J, Patel A, Kim H, Houser C, Sukumvanich P, Berger J, Boisen M, Edwards R, Taylor S, Courtney-Brooks M, Olawaiye A, Orr B, Beriwal S. PO-0178 Feasibility and Outcomes for Cervical Cancer Patients Treated with Hybrid Brachytherapy Applicators Radiotherapy and Oncology. 158: S141-S142. DOI: 10.1016/S0167-8140(21)06337-4 |
0.144 |
|
| 2006 |
Beriwal S, Jain SK, Heron DE, Kim H, Gerszten K, Edwards RP, Kelley JL. Clinical outcome with adjuvant treatment of endometrial carcinoma using intensity-modulated radiation therapy Gynecologic Oncology. 102: 195-199. PMID 16647748 DOI: 10.1016/j.ygyno.2006.01.062 |
0.144 |
|
| 1997 |
Edwards RP, Gooding W, Lembersky BC, Colonello K, Hammond R, Paradise C, Kowal CD, Kunschner AJ, Baldisseri M, Kirkwood JM, Herberman RB. Comparison of toxicity and survival following intraperitoneal recombinant interleukin-2 for persistent ovarian cancer after platinum: Twenty-four-hour versus 7-day infusion Journal of Clinical Oncology. 15: 3399-3407. PMID 9363872 DOI: 10.1200/JCO.1997.15.11.3399 |
0.143 |
|
| 2015 |
Vargo JA, Kim H, Houser CJ, Sukumvanich P, Olawaiye AB, Kelley JL, Edwards RP, Comerci JT, Huang M, Courtney-Brooks M, Beriwal S. Image-based multichannel vaginal cylinder brachytherapy for vaginal cancer. Brachytherapy. 14: 9-15. PMID 25456026 DOI: 10.1016/j.brachy.2014.10.001 |
0.143 |
|
| 2015 |
Hollestelle A, van der Baan FH, Berchuck A, Johnatty SE, Aben KK, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Anton-Culver H, Antonenkova NN, Antoniou AC, Apicella C, Arndt V, ... ... Edwards RP, et al. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology. PMID 25940428 DOI: 10.1016/J.Ygyno.2015.04.034 |
0.143 |
|
| 2004 |
Sit ASY, Kelley JL, Gallion HH, Kunschner AJ, Edwards RP. Paclitaxel and carboplatin for recurrent or persistent cancer of the cervix Cancer Investigation. 22: 368-373. PMID 15493357 DOI: 10.1081/CNV-200029062 |
0.142 |
|
| 2016 |
Boisen MM, Vargo JA, Beriwal S, Sukumvanich P, Olawaiye AB, Kelley JL, Edwards RP, Huang M, Courtney-Brooks M, Comerci JT. Surgical Outcomes of Patients Undergoing Extrafascial Hysterectomy After Neoadjuvant Radiotherapy With or Without Chemotherapy for Locally Advanced Endometrial Cancer Clinically Extending to the Cervix or Parametria. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 26825835 DOI: 10.1097/IGC.0000000000000614 |
0.142 |
|
| 2010 |
Wegner RE, Beriwal S, Heron DE, Richard SD, Kelly JL, Edwards RP, Sukumvanich P, Zorn KK, Krivak TC. Definitive radiation therapy for endometrial cancer in medically inoperable elderly patients. Brachytherapy. 9: 260-5. PMID 20122872 DOI: 10.1016/j.brachy.2009.08.013 |
0.142 |
|
| 2019 |
Gebhardt BJ, Rangaswamy B, Thomas J, Kelley J, Sukumvanich P, Edwards R, Comerci J, Olawaiye A, Courtney-Brooks M, Boisen M, Berger J, Beriwal S. Magnetic resonance imaging response in patients treated with definitive radiation therapy for medically inoperable endometrial cancer-Does it predict treatment response? Brachytherapy. PMID 31005602 DOI: 10.1016/j.brachy.2019.03.005 |
0.142 |
|
| 2020 |
Iheagwara UK, Vargo JA, Boisen MM, Taylor SE, Berger JL, Comerci JT, Orr BC, Sukumvanich P, Olawaiye AB, Kelley JL, Edwards RP, Courtney-Brooks MB, Beriwal S. Regional Control and Chemoradiotherapy Dose Response for Clinically Involved Lymph Nodes in Patients with Locally Advanced Endometrial Cancers Who are Not Candidates for Upfront Surgical Staging Extrafascial Hysterectomy. Clinical Oncology (Royal College of Radiologists (Great Britain)). PMID 32919862 DOI: 10.1016/J.Clon.2020.08.009 |
0.141 |
|
| 2010 |
Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, ... ... Edwards RP, et al. Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nature Genetics. 42: 880-4. PMID 20852633 DOI: 10.1038/Ng.666 |
0.141 |
|
| 2020 |
Richman AH, Patel AK, Rodríguez-López JL, Keller A, Vargo JA, Kim H, Sukumvanich P, Berger JL, Boisen MM, Edwards R, Taylor SE, Courtney-Brooks MB, Olawaiye A, Orr BC, Lesnock JL, et al. Do air gaps with image-guided vaginal cuff brachytherapy impact failure rates in patients with high-intermediate risk FIGO Stage I endometrial cancer? Brachytherapy. PMID 33384254 DOI: 10.1016/j.brachy.2020.11.012 |
0.141 |
|
| 2012 |
Skaznik-Wikiel ME, Sukumvanich P, Austin RM, Zorn KK, Krivak TC, Edwards RP, Olawaiye AB. Heavy cervical cancer burden in elderly women: how can we improve the situation? Acta Cytologica. 56: 388-93. PMID 22846717 DOI: 10.1159/000338555 |
0.141 |
|
| 2008 |
Coon D, Beriwal S, Heron DE, Kelley JL, Edwards RP, Sukumvanich P, Zorn KK, Krivak TC. High-dose-rate Rotte "Y" applicator brachytherapy for definitive treatment of medically inoperable endometrial cancer: 10-year results. International Journal of Radiation Oncology, Biology, Physics. 71: 779-83. PMID 18258388 DOI: 10.1016/j.ijrobp.2007.10.026 |
0.14 |
|
| 2007 |
Beriwal S, Heron DE, Mogus R, Edwards RP, Kelley JL, Sukumvanich P. High-dose-rate brachytherapy (HDRB) for primary or recurrent vaginal cancer Brachytherapy. 6: 115. DOI: 10.1016/J.BRACHY.2007.02.126 |
0.139 |
|
| 2007 |
Richard SD, Gusani N, Zeh HJ, Colovos C, Cho SW, Bartlett DL, Edwards RP. Morbidity and survival of 32 recurrent ovarian cancer patients treated with aggressive cytoreductive surgery followed by intraperitoneal hyperthermic chemoperfusion Journal of Clinical Oncology. 25: 16078-16078. DOI: 10.1200/jco.2007.25.18_suppl.16078 |
0.139 |
|
| 2010 |
Mantia-Smaldone GM, Budiu R, Mansuria S, Lee T, Zorn K, Elishaev E, Edwards RP, Vlad A. Abstract 1335: Immune regulation in endometriosis and epithelial ovarian cancer Cancer Research. 70: 1335-1335. DOI: 10.1158/1538-7445.Am10-1335 |
0.139 |
|
| 2010 |
Vergote I, Finkler NJ, Hall JB, Melnyk O, Edwards RP, Jones M, Keck JG, Meng L, Brown GL, Rankin EM, Burke JJ, Boccia RV, Runowicz CD, Rose PG. Randomized phase III study of canfosfamide in combination with pegylated liposomal doxorubicin compared with pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 20: 772-80. PMID 20973267 DOI: 10.1111/IGC.0b013e3181daaf59 |
0.139 |
|
| 2016 |
Taylor SE, Chu T, Edwards RP, Zorn KK. Phase II study of everolimus (EV) and bevacizumab (BEV) in recurrent ovarian, peritoneal, and fallopian tube cancer. Journal of Clinical Oncology. 34: 5552-5552. DOI: 10.1200/JCO.2016.34.15_SUPPL.5552 |
0.139 |
|
| 2020 |
Heayn M, Skvarca LB, Zhu L, Edwards RP, Olawaiye AB, Modugno F, Elishaev E, Bhargava R. Impact of Ki-67 Labeling Index on Prognostic Significance of the Chemotherapy Response Score in Women With Tubo-ovarian Cancer Treated With Neoadjuvant Chemotherapy. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. PMID 32897953 DOI: 10.1097/Pgp.0000000000000706 |
0.139 |
|
| 2007 |
Helm CW, Toler CR, Martin RS, Gordinier ME, Parker LP, Metzinger DS, Edwards RP. Cytoreduction and intraperitoneal heated chemotherapy for the treatment of endometrial carcinoma recurrent within the peritoneal cavity International Journal of Gynecological Cancer. 17: 204-209. PMID 17291254 DOI: 10.1111/j.1525-1438.2006.00751.x |
0.138 |
|
| 2011 |
Shukla G, Beriwal S, Krivak TC, Kelley JL, Sukumvanich P, Edwards RP, Richard S, Olawaiye A, Zorn KK. Preoperative high dose rate brachytherapy for clinical stage II endometrial carcinoma Journal of Contemporary Brachytherapy. 3: 70-73. DOI: 10.5114/jcb.2011.23200 |
0.138 |
|
| 2009 |
Braly P, Nicodemus CF, Chu C, Collins Y, Edwards R, Gordon A, McGuire W, Schoonmaker C, Whiteside T, Smith LM, Method M. The Immune adjuvant properties of front-line carboplatin-paclitaxel: a randomized phase 2 study of alternative schedules of intravenous oregovomab chemoimmunotherapy in advanced ovarian cancer. Journal of Immunotherapy (Hagerstown, Md. : 1997). 32: 54-65. PMID 19307994 DOI: 10.1097/CJI.0b013e31818b3dad |
0.138 |
|
| 2020 |
Richman A, Patel A, Rodriguez-Lopez J, Vargo J, Kim H, Sukumvanich P, Berger J, Boisen M, Edwards R, Taylor S, Courtney-Brooks M, Olawaiye A, Orr B, Lesnock J, Beriwal S. Do Air Gaps With Image-Guided Vaginal Cuff Brachytherapy Impact Failure Rates in High Intermediate Risk FIGO Stage I Endometrial Cancer Patients? International Journal of Radiation Oncology*Biology*Physics. 108: e462-e463. DOI: 10.1016/j.ijrobp.2020.07.2584 |
0.138 |
|
| 2000 |
Faul C, Gerszten K, Edwards R, Land S, D'Angelo G, Kelley J, Price F. A phase I/II study of hypofractionated whole abdominal radiation therapy in patients with chemoresistant ovarian carcinoma: Karnofsky score determines treatment outcome. International Journal of Radiation Oncology, Biology, Physics. 47: 749-54. PMID 10837960 DOI: 10.1016/S0360-3016(00)00446-6 |
0.138 |
|
| 2018 |
Horne ZD, Karukonda P, Kalash R, Edwards RP, Kelley JL, Comerci JT, Olawaiye AB, Courtney-Brooks M, Bochmeier MM, Berger JL, Taylor SE, Sukumvanich P, Beriwal S. Single-institution experience in 3D MRI-based brachytherapy for cervical cancer for 239 women: can dose overcome poor response? International Journal of Radiation Oncology, Biology, Physics. PMID 30605752 DOI: 10.1016/j.ijrobp.2018.12.042 |
0.137 |
|
| 2016 |
Donovan HS, Hagan TL, Campbell GB, Boisen MM, Rosenblum LM, Edwards RP, Bovbjerg DH, Horn CC. Nausea as a sentinel symptom for cytotoxic chemotherapy effects on the gut-brain axis among women receiving treatment for recurrent ovarian cancer: an exploratory analysis. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 26746209 DOI: 10.1007/S00520-015-3071-4 |
0.137 |
|
| 2017 |
Monk BJ, Brady MF, Aghajanian C, Lankes HA, Rizack T, Leach J, Fowler JM, Higgins R, Hanjani P, Morgan M, Edwards R, Bradley W, Kolevska T, Foukas P, Swisher E, et al. A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 28327944 DOI: 10.1093/annonc/mdx049 |
0.137 |
|
| 2017 |
Gebhardt B, Gill B, Glaser S, Kim H, Houser C, Kelley J, Sukumvanich P, Edwards R, Comerci J, Olawaiye A, Courtney-Brooks M, Boisen M, Berger J, Beriwal S. Image-guided tandem and cylinder brachytherapy as monotherapy for definitive treatment of inoperable endometrial carcinoma. Gynecologic Oncology. PMID 28923412 DOI: 10.1016/j.ygyno.2017.09.006 |
0.137 |
|
| 2019 |
Iheagwara UK, Vargo JA, Boisen MM, Taylor SE, Berger JL, Comerci JT, Orr BC, Sukumvanich P, Olawaiye AB, Kelley J, Edwards RP, Courtney-Brooks M, Beriwal S. Regional Control and Dose-Response for Chemoradiotherapy in Locally-Advanced Endometrial Cancer International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.322 |
0.137 |
|
| 2014 |
Vargo JA, Berhane H, Kim H, Houser C, Sukumvanich P, Olawaiye A, Kelley JL, Edwards RP, Krivak TC, Comerci J, Huang M, Courtney-Brooks M, Beriwal S. Image-Based High-Dose-Rate Brachytherapy Salvage for Vaginal Recurrences of Endometrial Cancer: The Interplay of PORTEC 1 Risk Stratification Brachytherapy. 13: S74-S75. DOI: 10.1016/J.BRACHY.2014.02.331 |
0.136 |
|
| 2017 |
Goode EL, Block MS, Kalli KR, Vierkant RA, Chen W, Fogarty ZC, Gentry-Maharaj A, Toloczko A, Hein A, Bouligny AL, Jensen A, Osorio A, Hartkopf AD, Ryan A, ... ... Edwards RP, et al. Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer. Jama Oncology. e173290. PMID 29049607 DOI: 10.1001/Jamaoncol.2017.3290 |
0.136 |
|
| 2011 |
Posluszny DM, Edwards RP, Dew MA, Baum A. Perceived threat and PTSD symptoms in women undergoing surgery for gynecologic cancer or benign conditions. Psycho-Oncology. 20: 783-7. PMID 20878863 DOI: 10.1002/pon.1771 |
0.135 |
|
| 2007 |
Wei S, Kryczek I, Edwards RP, Zou L, Szeliga W, Banerjee M, Cost M, Cheng P, Chang A, Redman B, Herberman RB, Zou W. Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma. Cancer Research. 67: 7487-94. PMID 17671219 DOI: 10.1158/0008-5472.Can-07-0565 |
0.135 |
|
| 2012 |
Beriwal S, Kannan N, Sukumvanich P, Richard SD, Kelley JL, Edwards RP, Olawaiye A, Krivak TC. Complete metabolic response after definitive radiation therapy for cervical cancer: patterns and factors predicting for recurrence. Gynecologic Oncology. 127: 303-6. PMID 22902917 DOI: 10.1016/j.ygyno.2012.08.006 |
0.135 |
|
| 2014 |
Sheikh MA, Althouse AD, Freese KE, Soisson S, Edwards RP, Welburn S, Sukumvanich P, Comerci J, Kelley J, LaPorte RE, Linkov F. USA endometrial cancer projections to 2030: should we be concerned? Future Oncology (London, England). 10: 2561-8. PMID 25531045 DOI: 10.2217/Fon.14.192 |
0.134 |
|
| 2016 |
Grabosch S, Zeng F, Zhang L, Ma T, Tseng G, Edwards RP, Vlad AM. Abstract 3208: Chemo-induced biology of PD-L1 andin vivocombination immune therapy for ovarian cancer Cancer Research. 76: 3208-3208. DOI: 10.1158/1538-7445.Am2016-3208 |
0.134 |
|
| 2009 |
Beriwal S, Kim H, Coon D, Mogus R, Krivak TC, Zorn KK, Sukumvanich P, Richard S, Kelley JL, Edwards RP. 3D HDR Intracavitary Brachytherapy for the Treatment of Cervical Cancer Feasibility and Early Results from Single Institution International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.843 |
0.134 |
|
| 2018 |
Gebhardt BJ, Vargo JA, Kim H, Houser CJ, Glaser SM, Sukumvanich P, Olawaiye AB, Kelley JL, Edwards RP, Comerci JT, Courtney-Brooks M, Beriwal S. Image-based Multichannel Vaginal Cylinder Brachytherapy for the Definitive Treatment of Vaginal Cancers International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.1783 |
0.134 |
|
| 2017 |
Praestegaard C, Jensen A, Jensen SM, Nielsen TS, Webb PM, Nagle CM, DeFazio A, Høgdall E, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Moysich K, ... ... Edwards R, et al. Cigarette smoking is associated with adverse survival among women with ovarian cancer: results from a pooled analysis of 19 studies. International Journal of Cancer. PMID 28063166 DOI: 10.1002/Ijc.30600 |
0.134 |
|
| 2016 |
Turaga KK, Gamblin TC, Alexander HR, Edwards R, Bartlett DL. Regional Therapies for Advanced Cancer: Update for 2016. Annals of Surgical Oncology. PMID 26732273 DOI: 10.1245/s10434-015-5068-0 |
0.134 |
|
| 2012 |
Beriwal S, Rwigema JC, Higgins E, Kim H, Houser C, Sukumvanich P, Olawaiye A, Richard S, Kelley JL, Edwards RP, Krivak TC. Three-dimensional image-based high-dose-rate interstitial brachytherapy for vaginal cancer. Brachytherapy. 11: 176-80. PMID 21665553 DOI: 10.1016/j.brachy.2011.05.005 |
0.133 |
|
| 2011 |
Taylor SE, McBee WC, Richard SD, Edwards RP. Radical hysterectomy for early stage cervical cancer: laparoscopy versus laparotomy. Jsls : Journal of the Society of Laparoendoscopic Surgeons / Society of Laparoendoscopic Surgeons. 15: 213-7. PMID 21902978 DOI: 10.4293/108680811X13022985132218 |
0.133 |
|
| 2011 |
Beriwal S, Kannan N, Kim H, Houser C, Mogus R, Sukumvanich P, Olawaiye A, Richard S, Kelley JL, Edwards RP, Krivak TC. Three-dimensional high dose rate intracavitary image-guided brachytherapy for the treatment of cervical cancer using a hybrid magnetic resonance imaging/computed tomography approach: feasibility and early results. Clinical Oncology (Royal College of Radiologists (Great Britain)). 23: 685-90. PMID 21908180 DOI: 10.1016/J.Clon.2011.08.007 |
0.133 |
|
| 2013 |
Kelemen LE, Bandera EV, Terry KL, Rossing MA, Brinton LA, Doherty JA, Ness RB, Kjaer SK, Chang-Claude J, Köbel M, Lurie G, Thompson PJ, Carney ME, Moysich K, Edwards R, et al. Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium. Bmc Cancer. 13: 28. PMID 23339562 DOI: 10.1186/1471-2407-13-28 |
0.133 |
|
| 2015 |
Mony JT, Zhang L, Ma T, Grabosch S, Tirodkar TS, Brozick J, Tseng G, Elishaev E, Edwards RP, Huang X, Vlad AM. Anti-PD-L1 prolongs survival and triggers T cell but not humoral anti-tumor immune responses in a human MUC1-expressing preclinical ovarian cancer model. Cancer Immunology, Immunotherapy : Cii. PMID 25998800 DOI: 10.1007/S00262-015-1712-6 |
0.133 |
|
| 2012 |
Obermajer N, Wong JL, Edwards RP, Odunsi K, Moysich K, Kalinski P. PGE(2)-driven induction and maintenance of cancer-associated myeloid-derived suppressor cells. Immunological Investigations. 41: 635-57. PMID 23017139 DOI: 10.3109/08820139.2012.695417 |
0.133 |
|
| 2012 |
Suryawanshi SM, Edwards R, Vlad A, Huang X. Abstract LB-479: Plasma microRNAs as novel biomarkers for endometriosis and endometriosis associates ovarian cancer Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-479 |
0.132 |
|
| 2016 |
Boisen M, Andersen C, Sikora M, Ma T, Tseng G, Vlad A, Elishaev E, Chandran U, Edwards R, Oesterreich S. The evolution of estrogen receptor signaling in the progression of endometriosis to endometriosis-associated ovarian cancer Gynecologic Oncology. 141: 113-114. DOI: 10.1016/J.Ygyno.2016.04.305 |
0.132 |
|
| 2016 |
Delgado E, Boisen MM, Laskey R, Chen R, Song C, Sallit J, Yochum ZA, Andersen CL, Sikora MJ, Wagner J, Safe S, Elishaev E, Lee A, Edwards RP, Haluska P, et al. High expression of orphan nuclear receptor NR4A1 in a subset of ovarian tumors with worse outcome. Gynecologic Oncology. PMID 26946093 DOI: 10.1016/J.Ygyno.2016.02.030 |
0.132 |
|
| 2012 |
Felix AS, Edwards RP, Stone RA, Chivukula M, Parwani AV, Bowser R, Linkov F, Weissfeld JL. Associations between hepatocyte growth factor, c-Met, and basic fibroblast growth factor and survival in endometrial cancer patients. British Journal of Cancer. 106: 2004-9. PMID 22617129 DOI: 10.1038/Bjc.2012.200 |
0.131 |
|
| 2014 |
Lesnock J, Gau D, Krivak T, Kelley J, Edwards R, Roy P. BRCA1 mutation determines the impact of profilin1 in ovarian cancer cell motility Gynecologic Oncology. 133: 106-107. DOI: 10.1016/J.YGYNO.2014.03.283 |
0.131 |
|
| 2013 |
Vargo JA, Beriwal S, Kim H, Houser C, Sukumvanich P, Olawaiye A, Kelley J, Edwards R, Krivak T. Three-Dimensional Image-Based High-Dose-Rate Brachytherapy Salvage for Recurrent Endometrial Cancer Brachytherapy. 12: S24-S25. DOI: 10.1016/J.BRACHY.2013.01.037 |
0.131 |
|
| 2011 |
Felix AS, Stone RA, Bowser R, Chivukula M, Edwards RP, Weissfeld JL, Linkov F. Comparison of survival outcomes between patients with malignant mixed mullerian tumors and high-grade endometrioid, clear cell, and papillary serous endometrial cancers. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 21: 877-84. PMID 21666484 DOI: 10.1097/Igc.0B013E31821A62Dd |
0.131 |
|
| 2015 |
Grabosch S, Mony JT, Zhang L, Ma T, Tirodkar T, Brozick J, Tseng G, Elishaev E, Edwards RP, Huang X, Vlad AM. Abstract 260: In vivo efficacy of intraperitoneal anti-PD-L1 therapy in ovarian cancer Cancer Research. 75: 260-260. DOI: 10.1158/1538-7445.Am2015-260 |
0.131 |
|
| 2014 |
Schreiber KL, Kehlet H, Belfer I, Edwards RR. Predicting, preventing and managing persistent pain after breast cancer surgery: the importance of psychosocial factors. Pain Management. 4: 445-59. PMID 25494696 DOI: 10.2217/Pmt.14.33 |
0.131 |
|
| 2017 |
Glaser S, Kalash R, Kim H, Christopher H, Boisen M, Comerci J, Sukumvanich P, Olawaiye A, Kelley J, Edwards R, Courtney-Brooks M, Berger J, Taylor S, Beriwal S. Image Based Brachytherapy with MRI-Based Planning in the Treatment of Cervical Cancer: A Single Institution Outcome Analysis of 220 Patients Brachytherapy. 16: S14. DOI: 10.1016/J.BRACHY.2017.04.007 |
0.131 |
|
| 2000 |
Sit ASY, Price FV, Kelley JL, Comerci JT, Kunschner AJ, Kanbour-Shakir A, Edwards RP. Chemotherapy for malignant mixed Mullerian tumors of the ovary Gynecologic Oncology. 79: 196-200. PMID 11063643 DOI: 10.1006/gyno.2000.5956 |
0.13 |
|
| 2015 |
Kar SP, Tyrer JP, Li Q, Lawrenson K, Aben KK, Anton-Culver H, Antonenkova N, Chenevix-Trench G, Baker H, Bandera E, Bean YT, Beckmann MW, Berchuck A, Bisogna M, Bjørge L, ... ... Edwards RP, et al. Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26209509 DOI: 10.1158/1055-9965.Epi-14-1270 |
0.13 |
|
| 2016 |
Ong JS, Cuellar-Partida G, Lu Y, Ovarian Cancer Study A, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Anne Doherty J, Anne Rossing M, Chang-Claude J, ... ... Edwards RP, et al. Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study. International Journal of Epidemiology. PMID 27594614 DOI: 10.1093/Ije/Dyw207 |
0.13 |
|
| 2018 |
Earp M, Tyrer JP, Winham SJ, Lin HY, Chornokur G, Dennis J, Aben KKH, Anton-Culver H, Antonenkova N, Bandera EV, Bean YT, Beckmann MW, Bjorge L, Bogdanova N, Brinton LA, ... ... Edwards RP, et al. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. Plos One. 13: e0197561. PMID 29979793 DOI: 10.1371/Journal.Pone.0197561 |
0.13 |
|
| 2011 |
Hoskins E, Hood B, Sun M, Krivak T, Conrads T, Edwards R. Detection of the tissue-derived biomarker peroxiredoxin 1 in serum of patients with ovarian cancer: A biomarker feasibility study Gynecologic Oncology. 120. DOI: 10.1016/J.Ygyno.2010.12.114 |
0.129 |
|
| 2012 |
Lin J, Hansen K, Beriwal S, Kelley J, Krivak T, Edwards R, Richard S, Olawaiye A, Zorn K, Sukumvanich P. Comparison of primary surgery versus definitive radiation for treatment of early endometrial cancer in the elderly population Gynecologic Oncology. 127: S13. DOI: 10.1016/J.YGYNO.2012.07.036 |
0.129 |
|
| 2017 |
Iheagwara UK, Burton D, Vargo JA, Boisen MM, Comerci JT, Kim H, Houser CJ, Sukumvanich P, Olawaiye AB, Kelley JL, Edwards RP, Courtney-Brooks M, Berger JL, Taylor SE, Beriwal S. Is There a Role of Neoadjuvant Radiotherapy Including High Dose Rate Image-Based Brachytherapy in Locally Advanced Type II Endometrial Cancer Clinically Extending to Cervix ± Parametria? Brachytherapy. 16. DOI: 10.1016/J.Brachy.2017.04.008 |
0.129 |
|
| 2015 |
Wang J, Hansen K, Edwards R, Van Houten B, Qian W. Mitochondrial division inhibitor 1 (mdivi-1) enhances death receptor-mediated apoptosis in human ovarian cancer cells. Biochemical and Biophysical Research Communications. 456: 7-12. PMID 25446129 DOI: 10.1016/j.bbrc.2014.11.010 |
0.129 |
|
| 2020 |
Pifer P, Bhargava R, Patel A, Ling D, Orr B, Sukumvanich P, Courtney-Brooks M, Boisen M, Berger J, Taylor S, Olawaiye A, Comerci J, Lesnock J, Edwards R, Vargo J, et al. Is the Risk of Substantial LVSI in Stage I Endometrial Cancer Similar to PORTEC in the North American Population? A Single Institution Study International Journal of Radiation Oncology*Biology*Physics. 108: S52. DOI: 10.1016/j.ijrobp.2020.07.2172 |
0.129 |
|
| 2009 |
Sepulveda AR, Jones D, Ogino S, Samowitz W, Gulley ML, Edwards R, Levenson V, Pratt VM, Yang B, Nafa K, Yan L, Vitazka P. CpG methylation analysis--current status of clinical assays and potential applications in molecular diagnostics: a report of the Association for Molecular Pathology. The Journal of Molecular Diagnostics : Jmd. 11: 266-78. PMID 19541921 DOI: 10.2353/jmoldx.2009.080125 |
0.129 |
|
| 2018 |
Hartnett E, Edwards R, Vlad A. Combination immune checkpoint blockade and MEK inhibition in a platinum-resistant ovarian cancer model Gynecologic Oncology. 149: 53-54. DOI: 10.1016/j.ygyno.2018.04.117 |
0.129 |
|
| 2023 |
Szabo PM, Vajdi A, Kumar N, Tolstorukov MY, Chen BJ, Edwards R, Ligon KL, Chasalow SD, Chow KH, Shetty A, Bolisetty M, Holloway JL, Golhar R, Kidd BA, Hull PA, et al. Cancer-associated fibroblasts are the main contributors to epithelial-to-mesenchymal signatures in the tumor microenvironment. Scientific Reports. 13: 3051. PMID 36810872 DOI: 10.1038/s41598-023-28480-9 |
0.129 |
|
| 2016 |
Boisen MM, Lesnock JL, Richard SD, Beriwal S, Kelley JL, Zorn KK, Edwards RP. Second-line intraperitoneal platinum-based therapy leads to an increase in second-line progression-free survival for epithelial ovarian cancer Obstetrical and Gynecological Survey. 71: 468-469. DOI: 10.1097/OGX.0000000000000350 |
0.128 |
|
| 2015 |
Lawrenson K, Li Q, Kar S, Seo JH, Tyrer J, Spindler TJ, Lee J, Chen Y, Karst A, Drapkin R, Aben KK, Anton-Culver H, Antonenkova N, Baker H, ... ... Edwards RP, et al. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. Nature Communications. 6: 8234. PMID 26391404 DOI: 10.1038/Ncomms9234 |
0.128 |
|
| 2015 |
Chen HJ, Sun J, Huang Z, Hou H, Arcilla M, Rakhilin N, Joe DJ, Choi J, Gadamsetty P, Milsom J, Nandakumar G, Longman R, Zhou XK, Edwards R, Chen J, et al. Comprehensive models of human primary and metastatic colorectal tumors in immunodeficient and immunocompetent mice by chemokine targeting. Nature Biotechnology. 33: 656-60. PMID 26006007 DOI: 10.1038/Nbt.3239 |
0.128 |
|
| 2018 |
Horne Z, Karukonda P, Kalash R, Edwards R, Kelley J, Comerci J, Olawaiye A, Courtney-Brooks M, Boisen M, Berger J, Taylor S, Sukumvanich P, Beriwal S. Single-Institution Experience in 3D MRI-Based Brachytherapy for Cervical Cancer for 230 Women: Can Dose Overcome Poor Response? International Journal of Radiation Oncology*Biology*Physics. 102: S222. DOI: 10.1016/j.ijrobp.2018.07.146 |
0.128 |
|
| 2011 |
Beriwal S, Kannan N, Kim H, Houser C, Mogus R, Sukumvanich P, Olawaiye A, Richard S, Kelley JL, Edwards RP, Krivak TC. 3D HDR Intracavitary Image Guided Brachytherapy for the Treatment of Cervical Cancer: Feasibility and Early Results Brachytherapy. 10: S56. DOI: 10.1016/J.BRACHY.2011.02.097 |
0.128 |
|
| 2021 |
Orellana T, Berger JL, Boisen MM, Buckanovich RJ, Coffman LG, Courtney-Brooks M, Edwards RP, Mahdi H, Olawaiye A, Sukumvanich P, Vargo J, Bhargava R, Beriwal S, Taylor SE, Smith K, et al. Cost-effectiveness analysis of p53 immunohistochemical testing in stage I and II high-risk endometrial cancer. Journal of Clinical Oncology. 39: e18838-e18838. DOI: 10.1200/JCO.2021.39.15_SUPPL.E18838 |
0.128 |
|
| 2014 |
Earp MA, Kelemen LE, Magliocco AM, Swenerton KD, Chenevix-Trench G, Lu Y, Hein A, Ekici AB, Beckmann MW, Fasching PA, Lambrechts D, Despierre E, Vergote I, ... ... Edwards RP, et al. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Human Genetics. 133: 481-97. PMID 24190013 DOI: 10.1007/S00439-013-1383-3 |
0.128 |
|
| 2019 |
Richman A, Ling D, Vargo J, Sukumvanich P, Berger J, Boisen M, Edwards R, Taylor S, Courtney-Brooks M, Olawaiye A, Orr B, Beriwal S. Dose-Escalated Intensity Modulated Radiation Therapy in Patients with Locally Advanced Vulvar Cancer- Does It Increase Response Rate? International Journal of Radiation Oncology*Biology*Physics. 105: E361. DOI: 10.1016/j.ijrobp.2019.06.1696 |
0.127 |
|
| 2013 |
Blakely T, Barendregt JJ, Foster RH, Hill S, Atkinson J, Sarfati D, Edwards R. The association of active smoking with multiple cancers: national census-cancer registry cohorts with quantitative bias analysis. Cancer Causes & Control : Ccc. 24: 1243-55. PMID 23580085 DOI: 10.1007/s10552-013-0204-2 |
0.127 |
|
| 2011 |
Posluszny DM, Baum A, Edwards RP, Dew MA. Posttraumatic growth in women one year after diagnosis for gynecologic cancer or benign conditions. Journal of Psychosocial Oncology. 29: 561-72. PMID 21882935 DOI: 10.1080/07347332.2011.599360 |
0.127 |
|
| 2010 |
Felix AS, Weissfeld JL, Stone RA, Bowser R, Chivukula M, Edwards RP, Linkov F. Factors associated with Type I and Type II endometrial cancer. Cancer Causes & Control : Ccc. 21: 1851-6. PMID 20628804 DOI: 10.1007/S10552-010-9612-8 |
0.127 |
|
| 2014 |
Shukla A, Edwards R, Yang Y, Hahn A, Folkers K, Ding J, Padmakumar VC, Cataisson C, Suh KS, Yuspa SH. CLIC4 regulates TGF-β-dependent myofibroblast differentiation to produce a cancer stroma. Oncogene. 33: 842-50. PMID 23416981 DOI: 10.1038/onc.2013.18 |
0.127 |
|
| 2007 |
Gayther SA, Song H, Ramus SJ, Kjaer SK, Whittemore AS, Quaye L, Tyrer J, Shadforth D, Hogdall E, Hogdall C, Blaeker J, DiCioccio R, McGuire V, Webb PM, Beesley J, ... ... Edwards RP, et al. Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Research. 67: 3027-35. PMID 17409409 DOI: 10.1158/0008-5472.Can-06-3261 |
0.127 |
|
| 2013 |
Pharoah PD, Tsai YY, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, Buckley M, Fridley BL, Tyrer JP, Shen H, Weber R, Karevan R, Larson MC, Song H, Tessier DC, ... ... Edwards R, et al. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nature Genetics. 45: 362-70, 370e1-2. PMID 23535730 DOI: 10.1038/Ng.2564 |
0.127 |
|
| 2015 |
Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM, Spindler TJ, Lin YG, Pejovic T, Bean Y, Li Q, ... ... Edwards RP, et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics. 47: 164-71. PMID 25581431 DOI: 10.1038/ng.3185 |
0.127 |
|
| 2013 |
Gamblin TC, Alexander HR, Edwards R, Bartlett DL. Regional therapies for cancer. Annals of Surgical Oncology. 20: 1053-5. PMID 23456388 DOI: 10.1245/s10434-013-2873-1 |
0.126 |
|
| 2008 |
Beriwal S, Coon D, Heron DE, Kelley JL, Edwards RP, Sukumvanich P, Zorn K, Krivak TC. High-dose-rate Rotte ‘Y’ applicator brachytherapy for definitive treatment of medically inoperable endometrial cancer: 10 years results Brachytherapy. 7: 151-152. DOI: 10.1016/J.BRACHY.2008.02.412 |
0.126 |
|
| 2002 |
Ravin AJ, Edwards RP, Krohn MA, Kelley JR, Christopherson WA, Roberts JM. The factor V Leiden mutation and the risk of venous thromboembolism in gynecologic oncology patients Obstetrics and Gynecology. 100: 1285-1289. PMID 12468175 DOI: 10.1016/S0029-7844(02)02320-7 |
0.126 |
|
| 2015 |
Amankwah EK, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, Beckmann MW, Bisogna M, Bjorge L, ... ... Edwards RP, et al. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. Genetic Epidemiology. PMID 26399219 DOI: 10.1002/Gepi.21921 |
0.126 |
|
| 2005 |
Gordon AN, Finkler N, Edwards RP, Garcia AA, Crozier M, Irwin DH, Barrett E. Efficacy and safety of erlotinib HCl, an epidermal growth factor receptor (HER1/EGFR) tyrosine kinase inhibitor, in patients with advanced ovarian carcinoma: Results from a phase II multicenter study International Journal of Gynecological Cancer. 15: 785-792. PMID 16174225 DOI: 10.1111/j.1525-1438.2005.00137.x |
0.126 |
|
| 2019 |
Keller A, Ling D, Vargo J, Sukumvanich P, Berger J, Boisen M, Edwards R, Taylor S, Courtney-Brooks M, Olawaiye A, Orr B, Beriwal S. Adjuvant Bone-Marrow Sparing IMRT in Endometrial Cancer Patients Treated with Sequential Chemotherapy- Does it Help with Completion Rate? International Journal of Radiation Oncology*Biology*Physics. 105: E351-E352. DOI: 10.1016/j.ijrobp.2019.06.1674 |
0.126 |
|
| 2010 |
Hirte HW, McGuire WP, Edwards RP, Husain A, Hoskins P, Michels JE, Matulonis U, Sexton C, Fox JA, Michelson G. Final results of a phase II study of voreloxin in women with platinum-resistant ovarian cancer. Journal of Clinical Oncology. 28: 5002-5002. DOI: 10.1200/JCO.2010.28.15_SUPPL.5002 |
0.125 |
|
| 2016 |
Cuellar-Partida G, Lu Y, Dixon SC, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Doherty JA, Rossing MA, Chang-Claude J, ... ... Edwards RP, et al. Assessing the genetic architecture of epithelial ovarian cancer histological subtypes. Human Genetics. PMID 27075448 DOI: 10.1007/S00439-016-1663-9 |
0.125 |
|
| 2021 |
Szabo PM, Pant S, Ely S, Desai K, Anguiano E, Wang L, Edwards R, Green G, Zhang N. Development and Performance of a CD8 Gene Signature for Characterizing Inflammation in the Tumor Microenvironment Across Multiple Tumor Types. The Journal of Molecular Diagnostics : Jmd. PMID 34197924 DOI: 10.1016/j.jmoldx.2021.06.002 |
0.125 |
|
| 2008 |
Ramus SJ, Vierkant RA, Johnatty SE, Pike MC, Van Den Berg DJ, Wu AH, Pearce CL, Menon U, Gentry-Maharaj A, Gayther SA, Dicioccio RA, McGuire V, Whittemore AS, Song H, Easton DF, ... ... Edwards RP, et al. Consortium analysis of 7 candidate SNPs for ovarian cancer. International Journal of Cancer. Journal International Du Cancer. 123: 380-8. PMID 18431743 DOI: 10.1002/Ijc.23448 |
0.125 |
|
| 2016 |
Clyde MA, Palmieri Weber R, Iversen ES, Poole EM, Doherty JA, Goodman MT, Ness RB, Risch HA, Rossing MA, Terry KL, Wentzensen N, Whittemore AS, Anton-Culver H, Bandera EV, Berchuck A, ... ... Edwards RP, et al. Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci. American Journal of Epidemiology. PMID 27698005 DOI: 10.1093/Aje/Kww091 |
0.124 |
|
| 2007 |
Edwards RP, Richard SD, Krivak TC, Zorn KK, Sukumvanich P, Kelley JL. Termination of intraperitoneal chemotherapy is driven by treatment toxicity rather than catheter dysfunction Journal of Clinical Oncology. 25: 16054-16054. DOI: 10.1200/jco.2007.25.18_suppl.16054 |
0.124 |
|
| 2018 |
Horne ZD, Kalash R, Edwards RP, Kelley J, Comerci JT, Olawaiye A, Courtney-Brookes M, Boisen M, Berger J, Sukumvanich P, Beriwal S. 3D MRI-Based Brachytherapy for Cervical Cancer: Can Dose Overcome Response? Brachytherapy. 17: S68. DOI: 10.1016/J.BRACHY.2018.04.112 |
0.124 |
|
| 2018 |
Yi Y, Bryce CL, Adambekov S, Edwards RP, Goughnour SL, Linkov F. Cost-effectiveness analysis of biopsy strategies for endometrial cancer diagnosis in women with postmenopausal bleeding: Pipelle sampling curette versus dilatation & curettage. Gynecologic Oncology. PMID 29747864 DOI: 10.1016/J.Ygyno.2018.04.565 |
0.124 |
|
| 2014 |
Tirodkar TS, Budiu RA, Elishaev E, Zhang L, Mony JT, Brozick J, Edwards RP, Vlad AM. MUC1 positive, Kras and Pten driven mouse gynecologic tumors replicate human tumors and vary in survival and nuclear grade based on anatomical location. Plos One. 9: e102409. PMID 25078979 DOI: 10.1371/Journal.Pone.0102409 |
0.123 |
|
| 2017 |
Rodríguez-Ubreva J, Català-Moll F, Obermajer N, Álvarez-Errico D, Ramirez RN, Company C, Vento-Tormo R, Moreno-Bueno G, Edwards RP, Mortazavi A, Kalinski P, Ballestar E. Prostaglandin E2 Leads to the Acquisition of DNMT3A-Dependent Tolerogenic Functions in Human Myeloid-Derived Suppressor Cells. Cell Reports. 21: 154-167. PMID 28978469 DOI: 10.1016/J.Celrep.2017.09.018 |
0.123 |
|
| 2016 |
Ager C, Reilley M, Nicholas C, Bartkowiak T, Jaiswal A, Curran M, Albershardt TC, Bajaj A, Archer JF, Reeves RS, Ngo LY, Berglund P, ter Meulen J, Denis C, Ghadially H, ... ... Edwards R, ... ... Edwards RP, ... ... Edwards RP, et al. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two Journal For Immunotherapy of Cancer. 4. DOI: 10.1186/S40425-016-0173-6 |
0.123 |
|
| 2012 |
Felix AS, Stone RA, Chivukula M, Bowser R, Parwani AV, Linkov F, Edwards RP, Weissfeld JL. Survival outcomes in endometrial cancer patients are associated with CXCL12 and estrogen receptor expression. International Journal of Cancer. Journal International Du Cancer. 131: E114-21. PMID 22025313 DOI: 10.1002/Ijc.27317 |
0.123 |
|
| 2019 |
Hand LC, Taylor SE, Lefkowits C, Thomas TH, Edwards RP, Donovan HS. Patient self-reporting as a low-intensity intervention for symptom management in ovarian cancer: An exploratory analysis of GOG-259 Gynecologic Oncology. 154. DOI: 10.1016/J.Ygyno.2019.03.165 |
0.123 |
|
| 2018 |
Dohopolski MJ, Horne ZD, Pradhan D, Bhargava R, Edwards RP, Kelley JL, Comerci JT, Olawaiye AB, Courtney-Brooks M, Berger JL, Sukumvanich P, Beriwal S. The prognostic significance of p16 status in patients with vulvar cancer treated with vulvectomy and adjuvant radiation. International Journal of Radiation Oncology, Biology, Physics. PMID 30121234 DOI: 10.1016/j.ijrobp.2018.08.014 |
0.122 |
|
| 2011 |
Kannan N, Beriwal S, Kim H, Houser C, Mogus R, Sukumvanich P, Olawaiye AB, Richard S, Kelley JL, Edwards RP. HDR Interstitial CT based Brachytherapy For the Treatment of Cervical Cancer: Early Results International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.975 |
0.121 |
|
| 2012 |
Kannan N, Sukumvanich P, Krivak T, Richard S, Kelley J, Edwards R, Olawaiye A, Beriwal S. Complete Metabolic Response After Definitive Radiation Therapy for Cervical Cancer: Patterns and Factors Predicting for Recurrence International Journal of Radiation Oncology*Biology*Physics. 84: S432. DOI: 10.1016/J.IJROBP.2012.07.1143 |
0.121 |
|
| 2011 |
Budiu RA, Elishaev E, Brozick J, Chu T, Predoiu S, Edwards RP, Vlad AM. Abstract 751: Vaccination with MUC1-pulsed dendritic cells prolongs survival in triple transgenic mice with orthotopic ovarian tumors Cancer Research. 71: 751-751. DOI: 10.1158/1538-7445.Am2011-751 |
0.121 |
|
| 2011 |
Obermajer N, Muthuswamy R, Lesnock J, Edwards RP, Kalinski P. Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells. Blood. 118: 5498-505. PMID 21972293 DOI: 10.1182/Blood-2011-07-365825 |
0.121 |
|
| 2020 |
Pifer PM, Bhargava R, Patel AK, Ling DC, Vargo JA, Orr BC, Sukumvanich P, Courtney-Brooks MB, Boisen MM, Berger JL, Taylor S, Olawaiye AB, Comerci JT, Lesnock JL, Edwards RP, et al. Is the risk of substantial LVSI in stage I endometrial cancer similar to PORTEC in the North American population? - A single-institution study. Gynecologic Oncology. PMID 32718729 DOI: 10.1016/j.ygyno.2020.07.024 |
0.121 |
|
| 2016 |
Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ, Heikkinen T, Nevanlinna H, Hopper JL, Dörk T, Claes KB, ... ... Edwards RP, et al. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. Journal of Medical Genetics. PMID 27595995 DOI: 10.1136/jmedgenet-2016-103839 |
0.12 |
|
| 2014 |
Gill BS, Kim H, Houser CJ, Kelley JL, Sukumvanich P, Edwards RP, Comerci J, Olawaiye A, Huang M, Courtney-Brooks M, Beriwal S. Extended Clinical Outcomes of 3D High-Dose-Rate Intracavitary Brachytherapy with MRI-Based Planning for Treatment of Cervical Cancer Brachytherapy. 13: S33. DOI: 10.1016/J.BRACHY.2014.02.247 |
0.12 |
|
| 2006 |
Gan G, Beriwal S, Heron D, Kelly J, Edwards R. 2815 International Journal of Radiation Oncology*Biology*Physics. 66: S668. DOI: 10.1016/J.IJROBP.2006.07.1233 |
0.12 |
|
| 2013 |
Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin HY, Chen YA, Tsai YY, Qu X, Ramus SJ, Karevan R, Lee J, Lee N, Larson MC, ... ... Edwards R, et al. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nature Communications. 4: 1627. PMID 23535648 DOI: 10.1038/Ncomms2613 |
0.119 |
|
| 2018 |
Gebhardt BJ, Vargo JA, Kim H, Houser CJ, Glaser SM, Sukumvanich P, Olawaiye AB, Kelley JL, Edwards RP, Comerci JT, Courtney-Brooks M, Beriwal S. Image-based multichannel vaginal cylinder brachytherapy for the definitive treatment of gynecologic malignancies in the vagina. Gynecologic Oncology. PMID 29929925 DOI: 10.1016/j.ygyno.2018.06.011 |
0.119 |
|
| 2010 |
Smaldone GMM, Richard SD, Edwards RP. Pregnancy outcomes after conservative surgical management of ovarian neoplasms treated at a single institution International Journal of Gynecological Cancer. 20: 926-931. PMID 20683397 DOI: 10.1111/IGC.0b013e3181e5c45a |
0.119 |
|
| 2013 |
Köbel M, Kalloger SE, Lee S, Duggan MA, Kelemen LE, Prentice L, Kalli KR, Fridley BL, Visscher DW, Keeney GL, Vierkant RA, Cunningham JM, Chow C, Ness RB, Moysich K, ... Edwards R, et al. Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1677-86. PMID 23880734 DOI: 10.1158/1055-9965.Epi-13-0391 |
0.119 |
|
| 2021 |
Baxi V, Edwards R, Montalto M, Saha S. Digital pathology and artificial intelligence in translational medicine and clinical practice. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 34611303 DOI: 10.1038/s41379-021-00919-2 |
0.119 |
|
| 2013 |
Belfer I, Schreiber KL, Shaffer JR, Shnol H, Blaney K, Morando A, Englert D, Greco C, Brufsky A, Ahrendt G, Kehlet H, Edwards RR, Bovbjerg DH. Persistent postmastectomy pain in breast cancer survivors: analysis of clinical, demographic, and psychosocial factors. The Journal of Pain : Official Journal of the American Pain Society. 14: 1185-95. PMID 23890847 DOI: 10.1016/J.Jpain.2013.05.002 |
0.119 |
|
| 2019 |
Adambekov S, Yi Y, Fabio A, Miljkovic I, Edwards RP, Lopa S, Linkov F. Metabolic Syndrome in Endometrial Cancer Patients: Systematic Review. Metabolic Syndrome and Related Disorders. PMID 30932741 DOI: 10.1089/Met.2018.0106 |
0.119 |
|
| 2005 |
Herzog T, Barret RJ, Edwards R, Oldham FB. Phase II study of paclitaxel poliglumex (PPX) /carboplatin (C) for 1st line induction and maintenance therapy of stage III/IV ovarian or primary peritoneal carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 5012. PMID 27946278 DOI: 10.1200/jco.2005.23.16_suppl.5012 |
0.119 |
|
| 2012 |
Boisen M, Lesnock J, McBee W, Richard S, Kelley J, Zorn K, Krivak T, Edwards R. CA125 surveillance and second-line intraperitoneal platinum-based therapy increases second line progression-free survival for epithelial ovarian cancer Gynecologic Oncology. 125: S110. DOI: 10.1016/J.YGYNO.2011.12.262 |
0.118 |
|
| 2015 |
Taylor SE, Li R, Petschauer JS, Donovan H, O'Neal S, Keeler AW, Zamboni WC, Edwards RP, Zorn KK. Phase I study of intravenous (IV) docetaxel and intraperitoneal (IP) oxaliplatin in recurrent ovarian and fallopian tube cancer. Gynecologic Oncology. PMID 26111788 DOI: 10.1016/J.Ygyno.2015.06.026 |
0.118 |
|
| 2011 |
Olson AC, Beriwal S, Kim H, Houser C, Wegner RE, Heron DE, Richard SD, Kelley JL, Edwards RP, Sukumvanich P. Dosimetry and Early Clinical Outcomes of 3D Treatment Planning for High Dose Rate Brachytherapy of Medically Inoperable Endometrial Cancer International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.757 |
0.118 |
|
| 2010 |
Olson AC, Beriwal S, Kim H, Houser C, Wegner RE, Heron DE, Richard SD, Kelly JL, Edwards RP, Sukumvanich P, Zorn KK, Krivak TC, Olawaiye AB. 3D Treatment Planning for Medically Inoperable Endometrial Cancer: Dosimetric Analysis and Early Clinical Outcomes Brachytherapy. 9: S27-S28. DOI: 10.1016/J.BRACHY.2010.02.017 |
0.118 |
|
| 2009 |
Finn OJ, Edwards RP. Human papillomavirus vaccine for cancer prevention. The New England Journal of Medicine. 361: 1899-901. PMID 19890134 DOI: 10.1056/Nejme0907480 |
0.118 |
|
| 2016 |
Wong JL, Obermajer N, Odunsi K, Edwards RP, Kalinski P. Synergistic COX2 induction by IFNγ and TNFα self-limits type-1 immunity in the human tumor microenvironment. Cancer Immunology Research. PMID 26817996 DOI: 10.1158/2326-6066.Cir-15-0157 |
0.117 |
|
| 2000 |
O'Rourkc N, Milne F, Edwards R. Radiotherapy treatment delays and lung cancer progression Lung Cancer. 29: 158. DOI: 10.1016/S0169-5002(00)80532-2 |
0.117 |
|
| 2014 |
Wong JL, Obermajer N, Muthuswamy R, Edwards RP, Odunsi K, Bartlett DL, Kalinski P. Activation of the COX2-PGE2 axis by immune effector cells results in the self-limiting nature of type-1 immunity in cancer tissues Journal For Immunotherapy of Cancer. 2. DOI: 10.1186/2051-1426-2-S3-P239 |
0.117 |
|
| 2016 |
Linkov F, Goughnour S, Edwards RP, Lokshin A, Ramanathan R, Hamad GG, Bovbjerg DH. Disparities in the ameliorative effects of bariatric surgery on endometrial cancer risk biomarkers. Journal of Clinical Oncology. 34: e13038-e13038. DOI: 10.1200/Jco.2016.34.15_Suppl.E13038 |
0.117 |
|
| 2007 |
Deloia J, Richard SD, Edwards RP, Elishaev E, Mason S, Shinde D, Mountz JJ, Bencherif B. Pilot study of FLT-PET/CT uptake in ovarian cancer patients with biologic correlates Journal of Clinical Oncology. 25: 16045-16045. DOI: 10.1200/JCO.2007.25.18_SUPPL.16045 |
0.117 |
|
| 2013 |
Suryawanshi S, Vlad A, Edwards R, Budiu R, Huang X. Abstract A75: miR-200 family in endometriosis-associated ovarian cancer Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-A75 |
0.117 |
|
| 2014 |
Gill BS, Kim H, Houser C, Olsen A, Kelley J, Edwards RP, Comerci J, Sukumvanich P, Olawaiye AB, Huang M, Courtney-Brooks M, Beriwal S. Image-based three-dimensional conformal brachytherapy for medically inoperable endometrial carcinoma. Brachytherapy. 13: 542-7. PMID 25127122 DOI: 10.1016/j.brachy.2014.07.002 |
0.117 |
|
| 2016 |
Hay CM, Courtney-Brooks M, Lefkowits C, Hagan TL, Edwards RP, Donovan HS. Symptom management in women with recurrent ovarian cancer: Do patients and clinicians agree on what symptoms are most important? Gynecologic Oncology. PMID 27531571 DOI: 10.1016/J.Ygyno.2016.08.235 |
0.116 |
|
| 2019 |
Meagher NS, Wang L, Rambau PF, Intermaggio MP, Huntsman DG, Wilkens LR, El-Bahrawy MA, Ness RB, Odunsi K, Steed H, Herpel E, Anglesio MS, Zhang B, Lambie N, Swerdlow AJ, ... ... Edwards RP, et al. A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 31239549 DOI: 10.1038/S41379-019-0302-0 |
0.116 |
|
| 2014 |
Boisen M, Lin J, Olawaiye A, Kelley J, Edwards R, Comerci J, Sukumvanich P. Does the order of surgery and radiation therapy matter in the treatment of stage II endometrial cancer? Gynecologic Oncology. 133: 138-139. DOI: 10.1016/j.ygyno.2014.03.362 |
0.116 |
|
| 2008 |
Richard SD, Krivak TC, Castleberry A, Beriwal S, Kelley JL, Edwards RP, Sukumvanich P. Survival for stage IB cervical cancer with positive lymph node involvement: a comparison of completed vs. abandoned radical hysterectomy. Gynecologic Oncology. 109: 43-8. PMID 18234297 DOI: 10.1016/j.ygyno.2007.12.002 |
0.116 |
|
| 2020 |
Alldredge J, Randall L, De Robles G, Agrawal A, Mercola D, Liu M, Randhawa P, Edwards R, McClelland M, Rahmatpanah F. Transcriptome Analysis of Ovarian and Uterine Clear Cell Malignancies. Frontiers in Oncology. 10: 598579. PMID 33415077 DOI: 10.3389/fonc.2020.598579 |
0.116 |
|
| 2009 |
Budiu RA, Diaconu I, Chrissluis R, Dricu A, Edwards RP, Vlad AM. A conditional mouse model for human MUC1-positive endometriosis shows the presence of anti-MUC1 antibodies and Foxp3+ regulatory T cells. Disease Models & Mechanisms. 2: 593-603. PMID 19841240 DOI: 10.1242/Dmm.002535 |
0.115 |
|
| 2012 |
Hansen K, Lin J, Beriwal S, Kelley J, Krivak T, Edwards R, Richard S, Olawaiye A, Zorn K, Sukumvanich P. A population-based study on post-operative outcomes of pelvic exenteration for gynecologic cancers Gynecologic Oncology. 125: S164. DOI: 10.1016/J.YGYNO.2011.12.404 |
0.115 |
|
| 2007 |
Beriwal S, Gan GN, Heron DE, Selvaraj RN, Kim H, Lalonde R, Kelley JL, Edwards RP. Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer. International Journal of Radiation Oncology, Biology, Physics. 68: 166-71. PMID 17321070 DOI: 10.1016/j.ijrobp.2006.12.023 |
0.115 |
|
| 2013 |
Robb KA, Lo SH, Power E, Kralj-Hans I, Edwards R, Vance M, von Wagner C, Atkin W, Wardle J. Patient-reported outcomes following flexible sigmoidoscopy screening for colorectal cancer in a demonstration screening programme in the UK. Journal of Medical Screening. PMID 23417540 DOI: 10.1177/0969141313476629 |
0.114 |
|
| 2011 |
Rwigema JM, Beriwal S, Higgins E, Kim H, Sukumvanich P, Olawaiye A, Richard S, Kelley JL, Edwards RP, Krivak TC. 3D Image-Based HDR Interstitial Brachytherapy for Vaginal Cancer Brachytherapy. 10: S21. DOI: 10.1016/J.BRACHY.2011.02.019 |
0.114 |
|
| 2012 |
Lo-Ciganic WH, Zgibor JC, Bunker CH, Moysich KB, Edwards RP, Ness RB. Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer. Epidemiology (Cambridge, Mass.). 23: 311-9. PMID 22252409 DOI: 10.1097/Ede.0B013E3182456Ad3 |
0.114 |
|
| 2016 |
Permuth JB, Pirie A, Chen YA, Lin HY, Reid BM, Chen Z, Monteiro A, Dennis J, Mendoza-Fandino G, Anton-Culver H, Bandera EV, Bisogna M, Brinton L, ... ... Edwards RP, et al. Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk. Human Molecular Genetics. PMID 27378695 DOI: 10.1093/Hmg/Ddw196 |
0.114 |
|
| 2016 |
Boisen MM, Lesnock JL, Richard SD, Beriwal S, Kelley JL, Zorn KK, Edwards RP. Second-line Intraperitoneal Platinum-based Therapy Leads to an Increase in Second-line Progression-free Survival for Epithelial Ovarian Cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 27051048 DOI: 10.1097/IGC.0000000000000667 |
0.114 |
|
| 2003 |
Kuss I, Rabinowich H, Gooding W, Edwards R, Whiteside TL. Expression of zeta in T cells prior to interleukin-2 therapy as a predictor of response and survival in patients with ovarian carcinoma. Cancer Biotherapy & Radiopharmaceuticals. 17: 631-40. PMID 12537666 DOI: 10.1089/108497802320970235 |
0.113 |
|
| 2017 |
Grabosch S, Zeng F, Ma T, Zhang L, Guido E, Tseng G, Edwards R, Vlad A, Brozick J. Novel combination immunotherapy with MUC1 vaccination and immune checkpoint blockade in ovarian cancer Gynecologic Oncology. 145: 86. DOI: 10.1016/J.Ygyno.2017.03.202 |
0.113 |
|
| 2017 |
Donovan H, Sereika S, Edwards R, Bender C, Given B, Hughes S, Klein S, Knapp J, Nolte S, Roberge M, Spring M, Wenzel L, Ward S. Effects of the WRITE Symptoms interventions on symptom and quality-of-life outcomes for women with recurrent ovarian cancer. GOG-259: An NRG Oncology/Gynecologic Oncology Group study Gynecologic Oncology. 145: 25-26. DOI: 10.1016/J.Ygyno.2017.03.073 |
0.113 |
|
| 2014 |
Pate KT, Stringari C, Sprowl-Tanio S, Wang K, TeSlaa T, Hoverter NP, McQuade MM, Garner C, Digman MA, Teitell MA, Edwards RA, Gratton E, Waterman ML. Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer. The Embo Journal. 33: 1454-73. PMID 24825347 DOI: 10.15252/Embj.201488598 |
0.113 |
|
| 1988 |
Kacinski BM, Carter D, Mittal K, Kohorn EI, Bloodgood RS, Donahue J, Donofrio L, Edwards R, Schwartz PE, Chambers JT. High level expression of fms proto-oncogene mRNA is observed in clinically aggressive human endometrial adenocarcinomas. International Journal of Radiation Oncology, Biology, Physics. 15: 823-9. PMID 3182322 DOI: 10.1016/0360-3016(88)90113-7 |
0.113 |
|
| 2009 |
Rollins-Raval M, Byler Dann R, Edwards RP, Chivukula M. Clinical outcome in patients with endometrial papillary serous and endometrioid carcinomas as related to WT-1, Pax-2, and p16 immunohistochemical expression profiles. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e16547. PMID 27960817 DOI: 10.1200/jco.2009.27.15_suppl.e16547 |
0.112 |
|
| 2016 |
Boisen M, Taylor S, Berger J, Johnson K, Kelley J, Edwards R, Olawaiye A, Huang M. Neoadjuvant chemotherapy in advanced-stage epithelial ovarian, fallopian tube, and primary peritoneal carcinoma: Do number of cycles matter? Gynecologic Oncology. 141: 191. DOI: 10.1016/J.YGYNO.2016.04.494 |
0.112 |
|
| 2013 |
Obermajer N, Wong JL, Edwards RP, Chen K, Scott M, Khader S, Kolls JK, Odunsi K, Billiar TR, Kalinski P. Development and stability of Th17 cells in ovarian cancer requires nitric oxide and endogenous NOS2 activity in cancer-associated CD4+ T cells Journal For Immunotherapy of Cancer. 1. DOI: 10.1186/2051-1426-1-S1-P146 |
0.111 |
|
| 2016 |
Grabosch S, Zeng F, Ma T, Zhang L, Brozick J, Tseng G, Edwards R, Vlad A. Chemo-induced biology of PD-L1 and in vivo combination immune therapy for ovarian cancer Gynecologic Oncology. 141: 86. DOI: 10.1016/J.Ygyno.2016.04.239 |
0.111 |
|
| 2013 |
Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, ... ... Edwards R, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature Genetics. 45: 371-84, 384e1-2. PMID 23535731 DOI: 10.1038/Ng.2566 |
0.11 |
|
| 2017 |
Linkov F, Goughnour SL, Ma T, Xu Z, Edwards RP, Lokshin AE, Ramanathan RC, Hamad GG, McCloskey C, Bovbjerg DH. Changes in inflammatory endometrial cancer risk biomarkers in individuals undergoing surgical weight loss. Gynecologic Oncology. PMID 28797697 DOI: 10.1016/J.Ygyno.2017.07.144 |
0.11 |
|
| 2017 |
Gebhardt B, Horne Z, Dohopolski M, Kelley J, Sukumvanich P, Edwards R, Comerci J, Olawaiye A, Courtney-Brooks M, Boisen M, Berger J, Beriwal S. Does Adjuvant Therapy Make a Difference for Stage 1A Type 2 Endometrial Cancer? International Journal of Radiation Oncology*Biology*Physics. 99: S229. DOI: 10.1016/J.IJROBP.2017.06.562 |
0.11 |
|
| 2018 |
Ross M, Tianzhou M, Zhang L, Tseng G, Edwards R, Vlad A. Immune checkpoint blockade and a neoepitope vaccine in a metastatic ovarian cancer model Gynecologic Oncology. 149: 83-84. DOI: 10.1016/J.Ygyno.2018.04.191 |
0.11 |
|
| 1997 |
Kowalski LD, Kanbour AI, Price FV, Finkelstein SD, Christopherson WA, Seski JC, Naus GJ, Burnham JA, Kanbour-Shakir A, Edwards RP. A case-matched molecular comparison of extraovarian versus primary ovarian adenocarcinoma. Cancer. 79: 1587-94. PMID 9118043 DOI: 10.1002/(SICI)1097-0142(19970415)79:8<1587::AID-CNCR22>3.0.CO;2-T |
0.11 |
|
| 2006 |
Beriwal S, Heron DE, Kim H, King G, Shogan J, Bahri S, Gerszten K, Lee J, Kelley J, Edwards RP. Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: a comparative dosimetric study with early clinical outcome. International Journal of Radiation Oncology, Biology, Physics. 64: 1395-400. PMID 16442238 DOI: 10.1016/j.ijrobp.2005.11.007 |
0.109 |
|
| 2018 |
Gebhardt BJ, Rangaswamy B, Thomas J, Kelley J, Sukumvanich P, Edwards RP, Comerci J, Olawaiye A, Courtney-Brooks M, Boisen M, Berger J, Beriwal S. Magnetic Resonance Imaging (MRI) Response in Patients Treated with Definitive Radiation Therapy for Medically Inoperable Endometrial Cancer - Does it Predict for Better Outcome? Brachytherapy. 17: S17. DOI: 10.1016/J.BRACHY.2018.04.014 |
0.108 |
|
| 2018 |
Linkov F, Goughnour SL, Adambekov S, Lokshin A, Kelley JL, Sukumvanich P, Comerci JT, Marra KG, Kokai LE, Rubin JP, Vlad AM, Philips BJ, Edwards RP. Inflammatory biomarker in adipose stem cells of women with endometrial cancer. Biomarkers in Medicine. PMID 30043637 DOI: 10.2217/Bmm-2017-0355 |
0.107 |
|
| 2014 |
Qian W, Wang J, Roginskaya V, McDermott LA, Edwards RP, Stolz DB, Llambi F, Green DR, Van Houten B. Novel combination of mitochondrial division inhibitor 1 (mdivi-1) and platinum agents produces synergistic pro-apoptotic effect in drug resistant tumor cells. Oncotarget. 5: 4180-94. PMID 24952704 DOI: 10.18632/Oncotarget.1944 |
0.107 |
|
| 2008 |
Beriwal S, Coon D, Heron DE, Kelley JL, Edwards RP, Sukumvanich P, Zorn KK, Krivak TC. Preoperative intensity-modulated radiotherapy and chemotherapy for locally advanced vulvar carcinoma. Gynecologic Oncology. 109: 291-5. PMID 18455637 DOI: 10.1016/j.ygyno.2007.10.026 |
0.107 |
|
| 2014 |
Linkov F, Burke LE, Komaroff M, Edwards RP, Lokshin A, Styn MA, Tseytlin E, Freese KE, Bovbjerg DH. An exploratory investigation of links between changes in adipokines and quality of life in individuals undergoing weight loss interventions: possible implications for cancer research. Gynecologic Oncology. 133: 67-72. PMID 24462731 DOI: 10.1016/J.Ygyno.2014.01.019 |
0.106 |
|
| 2011 |
Monk BJ, Sill MW, Hanjani P, Edwards R, Rotmensch J, De Geest K, Bonebrake AJ, Walker JL. Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimens: a phase II study of the Gynecologic Oncology Group. Gynecologic Oncology. 120: 459-63. PMID 21144560 DOI: 10.1016/J.Ygyno.2010.11.012 |
0.105 |
|
| 2014 |
Patel SA, Bhambra U, Charalambous MP, David RM, Edwards RJ, Lightfoot T, Boobis AR, Gooderham NJ. Interleukin-6 mediated upregulation of CYP1B1 and CYP2E1 in colorectal cancer involves DNA methylation, miR27b and STAT3. British Journal of Cancer. 111: 2287-96. PMID 25333344 DOI: 10.1038/bjc.2014.540 |
0.105 |
|
| 2013 |
Linkov FY, Komaroff M, Edwards R, Lokshin A, Styn M, Bovbjerg D, Burke L. Abstract 2521: Associations between changes in circulating inflammatory biomarkers and reduced BMI achieved in SMART and PREFER behavioral weight loss interventions. Cancer Research. 73: 2521-2521. DOI: 10.1158/1538-7445.Am2013-2521 |
0.105 |
|
| 2015 |
Stanciu MA, Morris C, Makin M, Watson E, Bulger J, Evans R, Hiscock J, Hoare Z, Edwards RT, Neal RD, Wilkinson C. A pilot randomised controlled trial of personalised care after treatment for prostate cancer (TOPCAT-P): nurse-led holistic-needs assessment and individualised psychoeducational intervention: study protocol. Bmj Open. 5: e008470. PMID 26112224 DOI: 10.1136/bmjopen-2015-008470 |
0.103 |
|
| 2015 |
Lawrenson K, Iversen ES, Tyrer J, Weber RP, Concannon P, Hazelett DJ, Li Q, Marks JR, Berchuck A, Lee JM, Aben KK, Anton-Culver H, Antonenkova N, ... ... Edwards RP, et al. Common Variants at the CHEK2 Gene Locus and Risk of Epithelial Ovarian Cancer. Carcinogenesis. PMID 26424751 DOI: 10.1093/carcin/bgv138 |
0.103 |
|
| 2016 |
Usset JL, Raghavan R, Tyrer JP, McGuire V, Sieh W, Webb P, Chang-Claude J, Rudolph A, Anton-Culver H, Berchuck A, Brinton LA, Cunningham JM, deFazio A, Doherty JA, Edwards RP, et al. Assessment of multifactor gene-environment interactions and ovarian cancer risk: candidate genes, obesity, and hormone-related risk factors. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26976855 DOI: 10.1158/1055-9965.Epi-15-1039 |
0.103 |
|
| 2015 |
Gill BS, Kim H, Houser CJ, Kelley JL, Sukumvanich P, Edwards RP, Comerci JT, Olawaiye AB, Huang M, Courtney-Brooks M, Beriwal S. MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: the University of Pittsburgh experience. International Journal of Radiation Oncology, Biology, Physics. 91: 540-7. PMID 25680598 DOI: 10.1016/j.ijrobp.2014.10.053 |
0.103 |
|
| 2018 |
Andersen CL, Boisen MM, Sikora MJ, Ma T, Tseng G, Suryawanshi S, Vlad A, Elishaev E, Edwards RP, Oesterreich S. The Evolution of Estrogen Receptor Signaling in the Progression of Endometriosis to Endometriosis-Associated Ovarian Cancer. Hormones & Cancer. PMID 30302736 DOI: 10.1007/S12672-018-0350-9 |
0.102 |
|
| 2014 |
Linkov F, Elishaev E, Gloyeske N, Edwards R, Althouse AD, Geller MA, Svendsen C, Argenta PA. Bariatric surgery-induced weight loss changes immune markers in the endometrium of morbidly obese women. Surgery For Obesity and Related Diseases : Official Journal of the American Society For Bariatric Surgery. 10: 921-6. PMID 25439003 DOI: 10.1016/J.Soard.2014.03.023 |
0.102 |
|
| 2020 |
Ling D, Thomas J, Vargo J, Orr B, Sukumvanich P, Berger J, Boisen M, Edwards R, Taylor S, Courtney-Brooks M, Olawaiye A, Beriwal S. PET-CT Directed IMRT-based Chemoradiation for Locally Advanced Vulvar Cancer - Analysis of Regional Recurrence Patterns International Journal of Radiation Oncology*Biology*Physics. 108: e469. DOI: 10.1016/j.ijrobp.2020.07.2599 |
0.102 |
|
| 2018 |
Rambau PF, Vierkant RA, Intermaggio MP, Kelemen LE, Goodman MT, Herpel E, Pharoah PD, Kommoss S, Jimenez-Linan M, Karlan BY, Gentry-Maharaj A, Menon U, Hernando Polo S, Candido Dos Reis FJ, Doherty JA, ... ... Edwards RP, et al. Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study. The Journal of Pathology. Clinical Research. PMID 30062862 DOI: 10.1002/cjp2.109 |
0.102 |
|
| 2015 |
Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, ... ... Edwards RP, et al. Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nature Genetics. 48: 101. PMID 26711112 DOI: 10.1038/Ng0116-101B |
0.1 |
|
| 2018 |
Kelemen LE, Earp M, Fridley BL, Chenevix-Trench G, Fasching PA, Beckmann MW, Ekici AB, Hein A, Lambrechts D, Lambrechts S, Van Nieuwenhuysen E, Vergote I, Rossing MA, Doherty JA, ... ... Edwards RP, et al. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology. International Journal of Molecular Sciences. 19. PMID 30134598 DOI: 10.3390/Ijms19092473 |
0.1 |
|
| 2018 |
Theodoraki MN, Yerneni S, Sarkar SN, Orr B, Muthuswamy R, Voyten J, Modugno F, Jiang W, Grimm M, Basse PH, Bartlett DL, Edwards R, Kalinski P. Helicase-driven activation of NFκB-COX2 mediates the immunosuppressive component of dsRNA-driven inflammation in the human tumor microenvironment. Cancer Research. PMID 29853604 DOI: 10.1158/0008-5472.Can-17-3985 |
0.099 |
|
| 2016 |
Grabosch S, Zeng F, Zhang L, Strange M, Brozick J, Edwards RP, Vlad A. Abstract A59: PD-L1 biology in response to chemotherapy in vitro and in vivo in ovarian cancer. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-A59 |
0.099 |
|
| 2015 |
Downs-Canner S, Ravindranathan R, Edwards RP, Kalinski P, Odunsi K, Bartlett DL, Obermajer N. Ex-Th17 Foxp3+ T cells - a novel subset of Foxp3+ T cells induced in cancer Journal For Immunotherapy of Cancer. 3: P273. DOI: 10.1186/2051-1426-3-S2-P273 |
0.099 |
|
| 2016 |
Gadzinski J, Taylor S, Courtney-Brooks M, Comerci J, Kelley J, Lin J, Olawaiye A, Edwards R, Beriwal S, Sukumvanich P. The increasing use of neoadjuvant chemotherapy for the treatment of epithelial ovarian carcinoma in the United States: A study of practice patterns Gynecologic Oncology. 141: 197. DOI: 10.1016/J.YGYNO.2016.04.508 |
0.099 |
|
| 2015 |
Loggia ML, Chonde DB, Akeju O, Arabasz G, Catana C, Edwards RR, Hill E, Hsu S, Izquierdo-Garcia D, Ji RR, Riley M, Wasan AD, Zürcher NR, Albrecht DS, Vangel MG, et al. Evidence for brain glial activation in chronic pain patients. Brain : a Journal of Neurology. 138: 604-15. PMID 25582579 DOI: 10.1093/Brain/Awu377 |
0.099 |
|
| 2018 |
Suarez Mora A, Taylor S, Olawaiye A, Beriwal S, Kelley J, Edwards R, Comerci J, Courtney-Brooks M, Boisen M, Berger J, Orr B, Sukumvanich P. Impact of histological grade on patients with clinical stage I endometrial carcinoma who received primary radiation therapy Gynecologic Oncology. 149: 147-148. DOI: 10.1016/j.ygyno.2018.04.337 |
0.099 |
|
| 2020 |
Donovan H, Thomas T, Boisen M, Campbell G, Edwards R, Hand L, Lee Y. Stability of symptoms and symptom clusters over time for women with recurrent ovarian cancer on GOG-259: A GOG/NRG Oncology study Gynecologic Oncology. 159: 60. DOI: 10.1016/j.ygyno.2020.06.125 |
0.099 |
|
| 2020 |
Linkov F, Adambekov S, Lopa S, Edwards RP, Rindos N, Mansuria S, Donnellan N, Bovbjerg DH. Abstract 2303: If at first you don't succeed: Follow-up care trajectories for women with failed endometrial biopsies Cancer Research. 80: 2303-2303. DOI: 10.1158/1538-7445.Am2020-2303 |
0.099 |
|
| 2015 |
Cadman L, Wilkes S, Mansour D, Austin J, Ashdown-Barr L, Edwards R, Kleeman M, Szarewski A. A randomized controlled trial in non-responders from Newcastle upon Tyne invited to return a self-sample for Human Papillomavirus testing versus repeat invitation for cervical screening. Journal of Medical Screening. 22: 28-37. PMID 25403717 DOI: 10.1177/0969141314558785 |
0.099 |
|
| 2009 |
Vergote I, Finkler NJ, Hall JB, Melnyk O, Edwards RP, Jones M, Meng L, Brown GL, Rankin EM, Burke JJ, Rose PG. Randomized phase III study of canfosfamide (C, TLK286) plus pegylated liposomal doxorubicin (PLD) versus PLD as second-line therapy in platinum (P) refractory or resistant ovarian cancer (OC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 5552. PMID 27962542 DOI: 10.1200/jco.2009.27.15_suppl.5552 |
0.098 |
|
| 2011 |
Richard SD, Bencherif B, Edwards RP, Elishaev E, Krivak TC, Mountz JM, DeLoia JA. Noninvasive assessment of cell proliferation in ovarian cancer using [ 18F] 3′deoxy-3-fluorothymidine positron emission tomography/computed tomography imaging Nuclear Medicine and Biology. 38: 485-491. PMID 21531285 DOI: 10.1016/j.nucmedbio.2010.12.003 |
0.098 |
|
| 2013 |
Meckes DG, Gunawardena HP, Dekroon RM, Heaton PR, Edwards RH, Ozgur S, Griffith JD, Damania B, Raab-Traub N. Modulation of B-cell exosome proteins by gamma herpesvirus infection. Proceedings of the National Academy of Sciences of the United States of America. 110: E2925-33. PMID 23818640 DOI: 10.1073/Pnas.1303906110 |
0.098 |
|
| 2016 |
Permuth JB, Reid B, Earp M, Chen YA, Monteiro AN, Chen Z, Aocs Study Group, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vanderstichele A, Van Niewenhuyse E, Vergote I, Rossing MA, ... ... Edwards RP, et al. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration. Oncotarget. 7: 72381-72394. PMID 27911851 DOI: 10.18632/Oncotarget.10546 |
0.098 |
|
| 2014 |
Yu M, Austin R, Lin J, Beck T, Beriwal S, Comerci J, Edwards R, Sukumvanich P, Kelley J, Olawaiye A. The diagnostic utility of HR-HPV as a predictor of cervical cancer recurrence Gynecologic Oncology. 133: 64. DOI: 10.1016/J.YGYNO.2014.03.173 |
0.098 |
|
| 2008 |
Fader AN, Edwards RP, Cost M, Kanbour-Shakir A, Kelley JL, Schwartz B, Sukumvanich P, Comerci J, Sumkin J, Elishaev E, Rohan LC. Sentinel lymph node biopsy in early-stage cervical cancer: utility of intraoperative versus postoperative assessment. Gynecologic Oncology. 111: 13-7. PMID 18684499 DOI: 10.1016/j.ygyno.2008.06.009 |
0.097 |
|
| 2012 |
Song G, Tarrant TK, Barrow DA, Gehrig PA, Hanna SK, Strychor S, Ramalingam S, Belani C, Edwards RP, Ramanathan RK, Zamboni WC. Abstract 754: The effect of CC chemokine ligand-2 (CCL2/MCP-1) and CC chemokine ligand-5 (CCL5/RANTES) on the pharmacokinetics (PK) and the pharmacodynamics (PD) of pegylated liposomal CKD602 (S-CKD602) in patients with advanced solid tumors Cancer Research. 72: 754-754. DOI: 10.1158/1538-7445.Am2012-754 |
0.097 |
|
| 2014 |
Reams C, Powell M, Edwards R. State synergies and disease surveillance: creating an electronic health data communication model for cancer reporting and comparative effectiveness research in kentucky. Egems (Washington, Dc). 2: 1064. PMID 25848604 DOI: 10.13063/2327-9214.1064 |
0.096 |
|
| 2014 |
Donovan HS, Ward SE, Sereika SM, Knapp JE, Sherwood PR, Bender CM, Edwards RP, Fields M, Ingel R. Web-based symptom management for women with recurrent ovarian cancer: a pilot randomized controlled trial of the WRITE Symptoms intervention. Journal of Pain and Symptom Management. 47: 218-30. PMID 24018206 DOI: 10.1016/J.Jpainsymman.2013.04.005 |
0.095 |
|
| 2011 |
Skaznik-Wikiel M, Sukumvanich P, Austin M, Zorn K, Krivak T, Edwards R, Olawaiye A. Cervical cancer screening in elderly patients: Should we discontinue screening at age 70? Gynecologic Oncology. 121: S3. DOI: 10.1016/J.YGYNO.2011.02.030 |
0.095 |
|
| 2016 |
Mansuria SM, Comerci J, Edwards R, Sanei Moghaddam A, Ma T, Linkov F. Changes in Hysterectomy Trends and Patient Outcomes Following the Implementation of a Clinical Pathway [7]. Obstetrics and Gynecology. 127: 3S. PMID 27176160 DOI: 10.1097/01.AOG.0000483623.30686.73 |
0.095 |
|
| 2003 |
Heron DE, Gerszten K, Selvaraj RN, King GC, Sonnik D, Gallion H, Comerci J, Edwards RP, Wu A, Andrade RS, Kalnicki S. Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: A comparative dosimetric study of dose-volume histograms Gynecologic Oncology. 91: 39-45. PMID 14529660 DOI: 10.1016/S0090-8258(03)00461-X |
0.095 |
|
| 2018 |
Jazaeri A, Edwards R, Zsiros E, Brown R, Gorbatchevsky I, Suzuki S, Wenham R. A phase II, multicenter study to evaluate the efficacy and safety using autologous tumor infiltrating lymphocytes (LN-145) in patients with recurrent, metastatic, or persistent cervical carcinoma Gynecologic Oncology. 149: 118. DOI: 10.1016/J.YGYNO.2018.04.274 |
0.095 |
|
| 2010 |
Chivukula M, Niemeier LA, Edwards R, Nikiforova M, Mantha G, McManus K, Carter G. Carcinomas of Distal Fallopian Tube and Their Association with Tubal Intraepithelial Carcinoma: Do They Share a Common "Precursor" Lesion? Loss of Heterozygosity and Immunohistochemical Analysis Using PAX 2, WT-1, and P53 Markers. Isrn Obstetrics and Gynecology. 2011: 858647. PMID 21826275 DOI: 10.5402/2011/858647 |
0.095 |
|
| 2007 |
Braly P, Chu C, Collins Y, Edwards R, Gordon A, McGuire W, Smith LM, Nicodemus C, Method M. Prospective evaluation of front-line chemo-immunotherapy (C-IT) with oregovomab (2 alternative dosing schedules) carboplatin-paclitaxel (C-P) in advanced ovarian cancer (OC) Journal of Clinical Oncology. 25: 3024-3024. DOI: 10.1200/JCO.2007.25.18_SUPPL.3024 |
0.094 |
|
| 2018 |
Jazaeri AA, Edwards RP, Wenham RM, MATSUO K, Fleming GF, O'Malley DM, Slomovitz BM, Monk BJ, Brown RJ, Suzuki S, Gorbatchevsky I, Fardis M, Zsiros E. A phase 2, multicenter study to evaluate the efficacy and safety using autologous tumor infiltrating lymphocytes (LN-145) in patients with recurrent, metastatic, or persistent cervical carcinoma. Journal of Clinical Oncology. 36: TPS5604-TPS5604. DOI: 10.1200/JCO.2018.36.15_SUPPL.TPS5604 |
0.094 |
|
| 2021 |
Mahadevan NR, Knelson EH, Wolff JO, Vajdi A, Saigi M, Campisi M, Hong D, Thai TC, Piel B, Han S, Reinhold BB, Duke-Cohan JS, Poitras MJ, Taus LJ, Lizotte PH, ... ... Edwards R, et al. Intrinsic immunogenicity of small cell lung carcinoma revealed by its cellular plasticity. Cancer Discovery. PMID 33707236 DOI: 10.1158/2159-8290.CD-20-0913 |
0.094 |
|
| 2013 |
Spaeth RB, Camhi S, Hashmi JA, Vangel M, Wasan AD, Edwards RR, Gollub RL, Kong J. A longitudinal study of the reliability of acupuncture deqi sensations in knee osteoarthritis. Evidence-Based Complementary and Alternative Medicine : Ecam. 2013: 204259. PMID 23935656 DOI: 10.1155/2013/204259 |
0.093 |
|
| 2007 |
Rose P, Edwards R, Finkler N, Seiden M, Duska L, Krasner C, Cappuccini F, Kolevska T, Brand E, Brown G, Runowicz C. Phase 3 Study: Canfosfamide (C, TLK286) plus carboplatin (P) vs liposomal doxorubicin (D) as 2nd line therapy of platinum (P) resistant ovarian cancer (OC) Journal of Clinical Oncology. 25: LBA5529-LBA5529. DOI: 10.1200/JCO.2007.25.18_SUPPL.LBA5529 |
0.093 |
|
| 2022 |
Baxi V, Lee G, Duan C, Pandya D, Cohen DN, Edwards R, Chang H, Li J, Elliott H, Pokkalla H, Glass B, Agrawal N, Lahiri A, Wang D, Khosla A, et al. Association of artificial intelligence-powered and manual quantification of programmed death-ligand 1 (PD-L1) expression with outcomes in patients treated with nivolumab ± ipilimumab. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 35840720 DOI: 10.1038/s41379-022-01119-2 |
0.092 |
|
| 2017 |
Andersen CL, Sikora MJ, Boisen MM, Ma T, Christie A, Tseng G, Park YS, Luthra S, Chandran U, Haluska P, Mantia-Smaldone G, Odunsi K, McLean K, Lee AV, Elishaev E, ... Edwards RP, et al. Active estrogen receptor-alpha signaling in ovarian cancer models and clinical specimens. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28073843 DOI: 10.1158/1078-0432.CCR-16-1501 |
0.092 |
|
| 1995 |
Edwards RP, Kuykendall K, Crowley-Nowick P, Partridge EE, Shingleton HM, Mestecky J. T lymphocytes infiltrating advanced grades of cervical neoplasia: CD8- Positive cells are recruited to invasion Cancer. 76: 1411-1415. PMID 8620416 DOI: 10.1002/1097-0142(19951015)76:8<1411::AID-CNCR2820760817>3.0.CO;2-V |
0.091 |
|
| 2015 |
Chen X, Spaeth RB, Freeman SG, Scarborough DM, Hashmi JA, Wey HY, Egorova N, Vangel M, Mao J, Wasan AD, Edwards RR, Gollub RL, Kong J. The modulation effect of longitudinal acupuncture on resting state functional connectivity in knee osteoarthritis patients. Molecular Pain. 11: 67. PMID 26511911 DOI: 10.1186/S12990-015-0071-9 |
0.091 |
|
| 2015 |
Edwards RK, Tang Y, Raglan GB, Szychowski JM, Schulkin J, Schrag SJ. Survey of American obstetricians regarding group B streptococcus: opinions and practice patterns. American Journal of Obstetrics and Gynecology. PMID 25816787 DOI: 10.1016/J.Ajog.2015.03.047 |
0.091 |
|
| 2004 |
Warrino DE, Olson WC, Knapp WT, Scarrow MI, D'Ambrosio-Brennan LJ, Guido RS, Edwards RP, Kast WM, Storkus WJ. Disease-stage variance in functional CD4+ T-cell responses against novel pan-human leukocyte antigen-D region presented human papillomavirus-16 E7 epitopes Clinical Cancer Research. 10: 3301-3308. PMID 15161683 DOI: 10.1158/1078-0432.Ccr-03-0498 |
0.091 |
|
| 2014 |
Vargo JA, Kim H, Choi S, Sukumvanich P, Olawaiye AB, Kelley JL, Edwards RP, Comerci JT, Beriwal S. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era. International Journal of Radiation Oncology, Biology, Physics. 90: 1091-8. PMID 25303889 DOI: 10.1016/j.ijrobp.2014.08.013 |
0.091 |
|
| 1996 |
Edwards RP, Pitts A, Crowley-Nowick P, Partridge EE, Gore H, Mestecky J. Immunoglobulin-containing plasma cells recruited to cervical neoplasia Obstetrics and Gynecology. 87: 520-526. PMID 8602302 DOI: 10.1016/0029-7844(95)00454-8 |
0.091 |
|
| 2014 |
Lim YW, Evangelista JS, Schmieder R, Bailey B, Haynes M, Furlan M, Maughan H, Edwards R, Rohwer F, Conrad D. Clinical insights from metagenomic analysis of sputum samples from patients with cystic fibrosis. Journal of Clinical Microbiology. 52: 425-37. PMID 24478471 DOI: 10.1128/Jcm.02204-13 |
0.09 |
|
| 2015 |
Subramaniam A, Kumar R, Cliver SP, Zhi D, Szychowski JM, Abramovici A, Biggio JR, Lefkowitz EJ, Morrow C, Edwards RK. Vaginal Microbiota in Pregnancy: Evaluation Based on Vaginal Flora, Birth Outcome, and Race. American Journal of Perinatology. PMID 26479170 DOI: 10.1055/S-0035-1565919 |
0.089 |
|
| 2015 |
Jamison RN, Martel MO, Huang CC, Jurcik D, Edwards RR. Efficacy of the Opioid Compliance Checklist to Monitor Chronic Pain Patients on Opioid Therapy in Primary Care. The Journal of Pain : Official Journal of the American Pain Society. PMID 26705974 DOI: 10.1016/J.Jpain.2015.12.004 |
0.089 |
|
| 2010 |
Combest AJ, Zorn KK, Edwards RP, Hanna SK, Habibi S, Strange M, Zamboni B, Krivak TC, Sukurmvanich P, Zamboni W. Pharmacokinetics (PK) of oxaliplatin (OX) after intraperitoneal (IP) and intravenous (IV) administration in patients with gynecological malignancies. Journal of Clinical Oncology. 28: 2584-2584. DOI: 10.1200/Jco.2010.28.15_Suppl.2584 |
0.089 |
|
| 2015 |
Kelemen LE, Lawrenson K, Tyrer J, Li Q, Lee JM, Seo JH, Phelan CM, Beesley J, Chen X, Spindler TJ, Aben KKH, Anton-Culver H, Antonenkova N, Baker H, Bandera EV, ... ... Edwards RP, et al. Genome-wide significant risk associations for mucinous ovarian carcinoma Nature Genetics. 47: 888-897. DOI: 10.1038/ng.3336 |
0.089 |
|
| 2013 |
Backonja MM, Attal N, Baron R, Bouhassira D, Drangholt M, Dyck PJ, Edwards RR, Freeman R, Gracely R, Haanpaa MH, Hansson P, Hatem SM, Krumova EK, Jensen TS, Maier C, et al. Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. Pain. 154: 1807-19. PMID 23742795 DOI: 10.1016/J.Pain.2013.05.047 |
0.089 |
|
| 2013 |
Obermajer N, Wong JL, Edwards RP, Chen K, Scott M, Khader S, Kolls JK, Odunsi K, Billiar TR, Kalinski P. Induction and stability of human Th17 cells require endogenous NOS2 and cGMP-dependent NO signaling. The Journal of Experimental Medicine. 210: 1433-445. PMID 23797095 DOI: 10.1084/Jem.20121277 |
0.088 |
|
| 2013 |
Wong JL, Berk E, Edwards RP, Kalinski P. IL-18-primed helper NK cells collaborate with dendritic cells to promote recruitment of effector CD8+ T cells to the tumor microenvironment. Cancer Research. 73: 4653-62. PMID 23761327 DOI: 10.1158/0008-5472.Can-12-4366 |
0.088 |
|
| 1994 |
Alvarez RD, Helm CW, Edwards RP, Naumann RW, Partridge EE, Shingleton HM, McGee JA, Hall JB, Higgins RV, Malone JM. Prospective randomized trial of LLETZ versus laser ablation in patients with cervical intraepithelial neoplasia Gynecologic Oncology. 52: 175-179. PMID 8314135 DOI: 10.1006/gyno.1994.1027 |
0.088 |
|
| 2015 |
Sutton AL, Sanders LB, Subramaniam A, Jauk VC, Edwards RK. Abdominal Incision Selection for Cesarean Delivery of Women with Class III Obesity. American Journal of Perinatology. PMID 26692204 DOI: 10.1055/s-0035-1570339 |
0.088 |
|
| 2015 |
Campbell CM, Carroll CP, Kiley K, Han D, Haywood C, Lanzkron S, Swedberg L, Edwards RR, Page GG, Haythornthwaite JA. Quantitative sensory testing and pain-evoked cytokine reactivity: Comparison of patients with sickle cell disease to healthy matched controls. Pain. PMID 26713424 DOI: 10.1097/J.Pain.0000000000000473 |
0.087 |
|
| 2010 |
Richard SD, Sukumvanich P, Lesnock JL, McBee WC, Beriwal S, Edwards RP, Zorn KK, Krivak TC. Intraperitoneal catheter leads to prolongation of the time to normalization of serum CA125 levels International Journal of Gynecological Cancer. 20: 932-935. PMID 20683398 DOI: 10.1111/IGC.0b013e3181e37a54 |
0.087 |
|
| 2002 |
Makhija S, Howden N, Edwards R, Kelley J, Townsend DW, Meltzer CC. Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: A retrospective review Gynecologic Oncology. 85: 53-58. PMID 11925120 DOI: 10.1006/Gyno.2002.6606 |
0.087 |
|
| 2013 |
Wideman TH, Asmundson GG, Smeets RJ, Zautra AJ, Simmonds MJ, Sullivan MJ, Haythornthwaite JA, Edwards RR. Rethinking the fear avoidance model: toward a multidimensional framework of pain-related disability. Pain. 154: 2262-5. PMID 23748115 DOI: 10.1016/J.Pain.2013.06.005 |
0.086 |
|
| 2015 |
Kaiyrlykyzy A, Freese KE, Elishaev E, Bovbjerg DH, Ramanathan R, Hamad GG, McCloskey C, Althouse AD, Huang M, Edwards RP, Linkov F. Endometrial histology in severely obese bariatric surgery candidates: an exploratory analysis. Surgery For Obesity and Related Diseases : Official Journal of the American Society For Bariatric Surgery. 11: 653-8. PMID 25820079 DOI: 10.1016/J.Soard.2014.12.010 |
0.086 |
|
| 2013 |
Martel MO, Wasan AD, Jamison RN, Edwards RR. Catastrophic thinking and increased risk for prescription opioid misuse in patients with chronic pain. Drug and Alcohol Dependence. 132: 335-41. PMID 23618767 DOI: 10.1016/J.Drugalcdep.2013.02.034 |
0.085 |
|
| 2013 |
Beriwal S, Shukla G, Shinde A, Heron DE, Kelley JL, Edwards RP, Sukumvanich P, Richards S, Olawaiye AB, Krivak TC. Preoperative intensity modulated radiation therapy and chemotherapy for locally advanced vulvar carcinoma: analysis of pattern of relapse. International Journal of Radiation Oncology, Biology, Physics. 85: 1269-74. PMID 23273997 DOI: 10.1016/j.ijrobp.2012.11.012 |
0.085 |
|
| 2014 |
Qian W, Wang J, Roginskaya V, McDermott L, Edwards R, Stolz D, Llambi F, Green D, Houten BV. Abstract 1683: Novel combination approach using platinum drugs and mitochondrial division inhibitor 1 (mdivi-1) overcomes platinum resistance by synergistically inducing mitochondrial outer membrane permeabilization (MOMP) and apoptosis independent of Drp1 Cancer Research. 74: 1683-1683. DOI: 10.1158/1538-7445.Am2014-1683 |
0.085 |
|
| 2008 |
Mcbee W, Richard S, Lesnock J, Sukumvanich P, Krivak T, Zorn K, Kelley J, Edwards R. A new modification of the standard IV/IP paclitaxel/cisplatin chemotherapy regimen that results in higher completion rates Gynecologic Oncology. 111: 373-374. DOI: 10.1016/J.YGYNO.2008.07.060 |
0.085 |
|
| 2013 |
Martel MO, Wasan AD, Edwards RR. Sex differences in the stability of conditioned pain modulation (CPM) among patients with chronic pain. Pain Medicine (Malden, Mass.). 14: 1757-68. PMID 23924369 DOI: 10.1111/Pme.12220 |
0.085 |
|
| 2010 |
Gardiner AS, McBee WC, Edwards RP, Austin M, Lesnock JL, Bhargava R, Guido R, Khan SA. MicroRNA analysis in human papillomavirus (HPV)-associated cervical neoplasia and cancer Infectious Agents and Cancer. 5. DOI: 10.1186/1750-9378-5-S1-A55 |
0.084 |
|
| 2016 |
He S, Gill BS, Heron DE, Kelley JL, Sukumvanich P, Olawaiye AB, Edwards RP, Comerci J, Beriwal S. Long-term outcomes using adjuvant pelvic intensity modulated radiation therapy (IMRT) for endometrial carcinoma. Practical Radiation Oncology. PMID 27527897 DOI: 10.1016/j.prro.2016.06.005 |
0.084 |
|
| 2015 |
Edwards RH, Marquitz AR, Raab-Traub N. Changes in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3. Mbio. 6. PMID 25873381 DOI: 10.1128/Mbio.00441-15 |
0.084 |
|
| 2017 |
Sanei-Moghaddam A, Goughnour S, Edwards R, Comerci J, Kelley J, Donnellan N, Linkov F, Mansuria S. Hysterectomy Pathway as the Global Engine of Practice Change: Implications for Value in Care. Central Asian Journal of Global Health. 6: 299. PMID 29138742 DOI: 10.5195/Cajgh.2017.299 |
0.084 |
|
| 2008 |
Latimer JJ, Johnson JM, Miles TD, Dimsdale JM, Edwards RP, Kelley JL, Grant SG. Cell-type-specific level of DNA nucleotide excision repair in primary human mammary and ovarian epithelial cell cultures. Cell and Tissue Research. 333: 461-7. PMID 18575893 DOI: 10.1007/S00441-008-0645-1 |
0.084 |
|
| 2015 |
Basaria S, Travison TG, Alford D, Knapp PE, Teeter K, Cahalan C, Eder R, Lakshman K, Bachman E, Mensing G, Martel MO, Le D, Stroh H, Bhasin S, Wasan AD, Edwards RR, et al. Effects of testosterone replacement in men with opioid-induced androgen deficiency: a randomized controlled trial. Pain. 156: 280-8. PMID 25599449 DOI: 10.1097/01.J.Pain.0000460308.86819.Aa |
0.083 |
|
| 2007 |
Kumar SM, Yu H, Edwards R, Chen L, Kazianis S, Brafford P, Acs G, Herlyn M, Xu X. Mutant V600E BRAF increases hypoxia inducible factor-1alpha expression in melanoma. Cancer Research. 67: 3177-84. PMID 17409425 DOI: 10.1158/0008-5472.Can-06-3312 |
0.083 |
|
| 1996 |
Rabinowich H, Suminami Y, Reichert TE, Crowley-Nowick P, Bell M, Edwards R, Whiteside TL. Expression of cytokine genes or proteins and signaling molecules in lymphocytes associated with human ovarian carcinoma. International Journal of Cancer. 68: 276-84. PMID 8903466 DOI: 10.1002/(SICI)1097-0215(19961104)68:3<276::AID-IJC2>3.0.CO;2-Z |
0.083 |
|
| 1995 |
Crowley-Nowick PA, Bell M, Edwards RP, McCallister D, Gore H, Kanbour-Shakir A, Mestecky J, Partridge EE. Normal uterine cervix: Characterization of isolated lymphocyte phenotypes and immunoglobulin secretion American Journal of Reproductive Immunology. 34: 241-247. PMID 8579762 DOI: 10.1111/j.1600-0897.1995.tb00948.x |
0.083 |
|
| 2008 |
Smalley KS, Contractor R, Nguyen TK, Xiao M, Edwards R, Muthusamy V, King AJ, Flaherty KT, Bosenberg M, Herlyn M, Nathanson KL. Identification of a novel subgroup of melanomas with KIT/cyclin-dependent kinase-4 overexpression. Cancer Research. 68: 5743-52. PMID 18632627 DOI: 10.1158/0008-5472.Can-08-0235 |
0.082 |
|
| 1991 |
Aubel S, Wozney P, Edwards RP. MRI of female uterine and juxta-uterine masses: Clinical application in 25 patients Magnetic Resonance Imaging. 9: 485-491. PMID 1779718 DOI: 10.1016/0730-725X(91)90033-I |
0.082 |
|
| 2018 |
Horne ZD, Dohopolski MJ, Pradhan D, Bhargava R, Edwards RP, Kelley JL, Comerci JT, Olawaiye AB, Courtney-Brooks MB, Bockmeier MM, Berger JL, Taylor SE, Sukumvanich P, Beriwal S. Human papillomavirus infection mediates response and outcome of vulvar squamous cell carcinomas treated with radiation therapy. Gynecologic Oncology. PMID 30082072 DOI: 10.1016/j.ygyno.2018.08.002 |
0.082 |
|
| 2008 |
Gusani NJ, Cho SW, Colovos C, Seo S, Franko J, Richard SD, Edwards RP, Brown CK, Holtzman MP, Zeh HJ, Bartlett DL. Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center. Annals of Surgical Oncology. 15: 754-63. PMID 18080166 DOI: 10.1245/s10434-007-9701-4 |
0.082 |
|
| 2014 |
Hsieh C, Kong J, Kirsch I, Edwards RR, Jensen KB, Kaptchuk TJ, Gollub RL. Well-loved music robustly relieves pain: a randomized, controlled trial. Plos One. 9: e107390. PMID 25211164 DOI: 10.1371/Journal.Pone.0107390 |
0.081 |
|
| 2016 |
Subramaniam A, Jacobs AP, Tang Y, Neely C, Philips JB, Biggio JR, Robin NH, Edwards RK. Trisomy 18: A single-center evaluation of management trends and experience with aggressive obstetric or neonatal intervention. American Journal of Medical Genetics. Part A. PMID 26728763 DOI: 10.1002/ajmg.a.37529 |
0.081 |
|
| 2013 |
Thomson CE, Beggs I, Martin DJ, McMillan D, Edwards RT, Russell D, Yeo ST, Russell IT, Gibson JN. Methylprednisolone injections for the treatment of Morton neuroma: a patient-blinded randomized trial. The Journal of Bone and Joint Surgery. American Volume. 95: 790-8, S1. PMID 23636185 DOI: 10.2106/JBJS.I.01780 |
0.081 |
|
| 2011 |
Shukla G, Beriwal S, Krivak TC, Kelley JL, Sukumvanitch P, Edwards RP, Richard S, Olawaiye A, Zorn KK. Preoperative High-Dose-Rate Brachytherapy for Clinical Stage IIB Endometrial Carcinoma Brachytherapy. 10: S62. DOI: 10.1016/J.BRACHY.2011.02.111 |
0.081 |
|
| 2013 |
Khalil H, Nie W, Edwards RA, Yoo J. Isolation of primary myofibroblasts from mouse and human colon tissue. Journal of Visualized Experiments : Jove. PMID 24145735 DOI: 10.3791/50611 |
0.081 |
|
| 2018 |
Horne Z, Dohopolski M, Pradhan D, Bhargava R, Edwards R, Kelley J, Comerci J, Olawaiye A, Courtney-Brooks M, Boisen M, Berger J, Taylor S, Sukumvanich P, Beriwal S. Chemoradiation Therapy for Vulvar Squamous Cell Carcinoma: Does p16-Positivity Predict for Better Response Rates and Outcomes? International Journal of Radiation Oncology*Biology*Physics. 102: S84-S85. DOI: 10.1016/j.ijrobp.2018.06.223 |
0.08 |
|
| 2022 |
Hayes DF, Herbst RS, Myles JL, Topalian SL, Yohe SL, Aronson N, Bellizzi AM, Basu Roy U, Bradshaw G, Edwards RH, El-Gabry EA, Elvin J, Gajewski TF, McShane LM, Oberley M, et al. Proceedings From the ASCO/College of American Pathologists Immune Checkpoint Inhibitor Predictive Biomarker Summit. Jco Precision Oncology. 6: e2200454. PMID 36446042 DOI: 10.1200/PO.22.00454 |
0.08 |
|
| 2013 |
Smith SM, Dart RC, Katz NP, Paillard F, Adams EH, Comer SD, Degroot A, Edwards RR, Haddox JD, Jaffe JH, Jones CM, Kleber HD, Kopecky EA, Markman JD, Montoya ID, et al. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain. 154: 2287-96. PMID 23792283 DOI: 10.1016/J.Pain.2013.05.053 |
0.08 |
|
| 2020 |
Adambekov S, Lopa S, Elishaev E, Rindos N, Mansuria S, Edwards RP, Bovbjerg DH, Donnellan N, Linkov F. Abstract 5777: Risk factors associated with Pipelle endometrial biopsy failure Epidemiology. 80: 5777-5777. DOI: 10.1158/1538-7445.Am2020-5777 |
0.08 |
|
| 2014 |
Kelemen LE, Terry KL, Goodman MT, Webb PM, Bandera EV, McGuire V, Rossing MA, Wang Q, Dicks E, Tyrer JP, Song H, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Timorek A, ... ... Edwards RP, et al. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Molecular Nutrition & Food Research. 58: 2023-35. PMID 25066213 DOI: 10.1002/Mnfr.201400068 |
0.079 |
|
| 2015 |
Railsback LB, Brook GA, Ellwood BB, Liang F, Cheng H, Edwards RL. A record of wet glacial stages and dry interglacial stages over the last 560kyr from a standing massive stalagmite in Carlsbad Cavern, New Mexico, USA Palaeogeography, Palaeoclimatology, Palaeoecology. 438: 256-266. DOI: 10.1016/J.Palaeo.2015.08.010 |
0.079 |
|
| 2013 |
Patel A, Edwards R, Chandramohan S. Surveillance of patients post-endovascular abdominal aortic aneurysm repair (EVAR). A web-based survey of practice in the UK. Clinical Radiology. 68: 580-7. PMID 23541091 DOI: 10.1016/J.Crad.2012.11.019 |
0.079 |
|
| 2004 |
Gorelik E, Edwards RP, Feng X, Marrangoni AM, Grandis JR, Drenning SD, Velikokhatnaya L, Kwon JA, Lokshin AE. IL-12 receptor-mediated upregulation of FasL in human ovarian carcinoma cells International Journal of Cancer. 112: 620-627. PMID 15382042 DOI: 10.1002/Ijc.20482 |
0.079 |
|
| 2015 |
Deeny MC, Al Hamdan E, Ross EL, Edwards RR, Huang CC, Jamison RN. Chronic Pain, Comorbid Medical Conditions, and Associated Risk Factors in Kuwait: Gender and Nationality Differences. Pain Medicine (Malden, Mass.). PMID 26118589 DOI: 10.1111/Pme.12840 |
0.079 |
|
| 2011 |
Padilla-Raygoza N, LaPorte R, Shubnikov E, Hennon M, Edwards RP, Linkov F. Cancer and chronic diseases in minority populations: the need for more educational materials in Spanish for healthcare providers. Journal of Immigrant and Minority Health / Center For Minority Public Health. 13: 1180-2. PMID 21559967 DOI: 10.1007/S10903-011-9475-4 |
0.078 |
|
| 2014 |
Hoffman JL, Gray RG, LuAnn Minich L, Wilkinson SE, Heywood M, Edwards R, Weng HT, Su JT. Screening for aortic aneurysm after treatment of coarctation. Pediatric Cardiology. 35: 47-52. PMID 23794012 DOI: 10.1007/s00246-013-0737-x |
0.078 |
|
| 2018 |
Gadzinski J, Yu L, Sukumvanich P, Berger J, Courtney-Brooks M, Olawaiye A, Boisen M, Edwards R, Kelley J, Taylor S. SGO member practice patterns for intraoperative assessment of and decision making regarding lymph nodes for cervical cancer: Should we abandon the radical hysterectomy? Gynecologic Oncology. 149: 104. DOI: 10.1016/J.YGYNO.2018.04.241 |
0.078 |
|
| 2011 |
Edwards RP. Is hyperthermic intraoperative peritoneal chemotherapy and systemic chemotherapy as effective as standard intraperitoneal chemotherapy: Time for a prospective trial? Gynecologic Oncology. 122: 207-208. PMID 21763889 DOI: 10.1016/j.ygyno.2011.06.029 |
0.078 |
|
| 2009 |
Zamboni WC, Strychor S, Maruca L, Ramalingam S, Zamboni BA, Wu H, Friedland DM, Edwards RP, Stoller RG, Belani CP, Ramanathan RK. Pharmacokinetic study of pegylated liposomal CKD-602 (S-CKD602) in patients with advanced malignancies Clinical Pharmacology and Therapeutics. 86: 519-526. PMID 19675541 DOI: 10.1038/Clpt.2009.141 |
0.078 |
|
| 2015 |
Sanchez SE, Cuevas DA, Rostron JE, Liang TY, Pivaroff CG, Haynes MR, Nulton J, Felts B, Bailey BA, Salamon P, Edwards RA, Burgin AB, Segall AM, Rohwer F. Phage Phenomics: Physiological Approaches to Characterize Novel Viral Proteins. Journal of Visualized Experiments : Jove. PMID 26132888 DOI: 10.3791/52854 |
0.078 |
|
| 2015 |
Edwards RG, Kopp SJ, Karaba AH, Wilcox DR, Longnecker R. Herpesvirus Entry Mediator on Radiation-Resistant Cell Lineages Promotes Ocular Herpes Simplex Virus 1 Pathogenesis in an Entry-Independent Manner. Mbio. 6. PMID 26489863 DOI: 10.1128/Mbio.01532-15 |
0.078 |
|
| 2013 |
Poi MJ, Hofmeister CC, Johnston JS, Edwards RB, Jansak BS, Lucas DM, Farag SS, Dalton JT, Devine SM, Grever MR, Phelps MA. Standard pentostatin dose reductions in renal insufficiency are not adequate: selected patients with steroid-refractory acute graft-versus-host disease. Clinical Pharmacokinetics. 52: 705-12. PMID 23588536 DOI: 10.1007/S40262-013-0064-7 |
0.078 |
|
| 2021 |
Qi M, Lopa S, Adambekov S, Harris JA, Mansuria S, Edwards RP, Linkov F. Same-day discharge after minimal invasive hysterectomy: Applications for improved value of care. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 259: 140-145. PMID 33667895 DOI: 10.1016/j.ejogrb.2021.02.020 |
0.078 |
|
| 2013 |
Cummins I, Wortley DJ, Sabbadin F, He Z, Coxon CR, Straker HE, Sellars JD, Knight K, Edwards L, Hughes D, Kaundun SS, Hutchings SJ, Steel PG, Edwards R. Key role for a glutathione transferase in multiple-herbicide resistance in grass weeds. Proceedings of the National Academy of Sciences of the United States of America. 110: 5812-7. PMID 23530204 DOI: 10.1073/Pnas.1221179110 |
0.077 |
|
| 2003 |
Siervo-Sassi RR, Marrangoni AM, Feng X, Naoumova N, Winans M, Edwards RP, Lokshin A. Physiological and molecular effects of Apo2L/TRAIL and cisplatin in ovarian carcinoma cell lines Cancer Letters. 190: 61-72. PMID 12536078 DOI: 10.1016/S0304-3835(02)00579-7 |
0.077 |
|
| 2014 |
Edwards RL, Lofgren RP, Birdwhistell MD, Zembrodt JW, Karpf M. Challenges of becoming a regional referral system: the University of Kentucky as a case study. Academic Medicine : Journal of the Association of American Medical Colleges. 89: 224-9. PMID 24362394 DOI: 10.1097/ACM.0000000000000114 |
0.077 |
|
| 2014 |
Issa MA, Narang S, Jamison RN, Michna E, Edwards RR, Penetar DM, Wasan AD. The subjective psychoactive effects of oral dronabinol studied in a randomized, controlled crossover clinical trial for pain. The Clinical Journal of Pain. 30: 472-8. PMID 24281276 DOI: 10.1097/Ajp.0000000000000022 |
0.077 |
|
| 2014 |
Barua NU, Hopkins K, Woolley M, O'Sullivan S, Harrison R, Edwards RJ, Bienemann AS, Wyatt MJ, Arshad A, Gill SS. A novel implantable catheter system with transcutaneous port for intermittent convection-enhanced delivery of carboplatin for recurrent glioblastoma. Drug Delivery. PMID 24786643 DOI: 10.3109/10717544.2014.908248 |
0.077 |
|
| 2013 |
Berger J, Smith A, Zorn K, Sukumvanich P, Olawaiye A, Edwards R, Kelley J, Krivak T. In recurrent epithelial ovarian carcinoma during the drug shortage era Gynecologic Oncology. 131: 268-269. DOI: 10.1016/J.Ygyno.2013.07.058 |
0.077 |
|
| 2004 |
Randall-Whitis L, Helm CW, Toler CR, Martin RS, Metzinger DS, Edwards RP. Secondary surgical cytoreduction and hyperthermic intraperitoneal chemoperfusion (SSC-HIPEC) for recurrent gynecologic malignancies Journal of Clinical Oncology. 22: 5096-5096. DOI: 10.1200/JCO.2004.22.90140.5096 |
0.076 |
|
| 2017 |
Sanei-Moghaddam A, Kang C, Edwards RP, Lounder PJ, Ismail N, Goughnour SL, Mansuria SM, Comerci JT, Linkov F. Racial and Socioeconomic Disparities in Hysterectomy Route for Benign Conditions. Journal of Racial and Ethnic Health Disparities. PMID 28840507 DOI: 10.1007/S40615-017-0420-7 |
0.076 |
|
| 2017 |
Linkov F, Sanei-Moghaddam A, Edwards RP, Lounder PJ, Ismail N, Goughnour SL, Kang C, Mansuria SM, Comerci JT. Implementation of Hysterectomy Pathway: Impact on Complications. Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health. PMID 28347618 DOI: 10.1016/J.Whi.2017.02.004 |
0.076 |
|
| 2015 |
Shmeleva EV, Boag SE, Murali S, Bennaceur K, Das R, Egred M, Purcell I, Edwards R, Todryk S, Spyridopoulos I. Differences in immune responses between CMV-seronegative and -seropositive patients with myocardial ischemia and reperfusion. Immunity, Inflammation and Disease. 3: 56-70. PMID 26029366 DOI: 10.1002/iid3.49 |
0.076 |
|
| 2015 |
Cantu JA, Jauk VR, Owen J, Biggio JR, Abramovici AR, Edwards RK, Tita AT. Is low-dose aspirin therapy to prevent preeclampsia more efficacious in non-obese women or when initiated early in pregnancy? The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 1-5. PMID 25048750 DOI: 10.3109/14767058.2014.947258 |
0.076 |
|
| 2016 |
Orr B, Lin J, Edwards R, Kelley J, Olawaiye A, Comerci J, Huang M, Courtney-Brooks M, Taylor S, Sukumvanich P. Undifferentiated endometrial sarcoma: Does adjuvant treatment impact outcomes of stage I disease? Gynecologic Oncology. 141: 120. DOI: 10.1016/J.YGYNO.2016.04.321 |
0.076 |
|
| 2013 |
Borsook D, Edwards R, Elman I, Becerra L, Levine J. Pain and analgesia: the value of salience circuits. Progress in Neurobiology. 104: 93-105. PMID 23499729 DOI: 10.1016/J.Pneurobio.2013.02.003 |
0.076 |
|
| 2015 |
Hess PL, Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, Buxton A, Cappato R, Dorian P, Hallstrom A, Kadish AH, Kudenchuk PJ, Lee KL, Mark DB, Moss AJ, et al. Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials. Circulation. Cardiovascular Quality and Outcomes. 8: 179-86. PMID 25669833 DOI: 10.1161/CIRCOUTCOMES.114.001306 |
0.076 |
|
| 2012 |
Wu H, Ramanathan RK, Zamboni BA, Strychor S, Ramalingam S, Edwards RP, Friedland DM, Stoller RG, Belani CP, Maruca LJ, Bang YJ, Zamboni WC. Population pharmacokinetics of pegylated liposomal CKD-602 (S-CKD602) in patients with advanced malignancies. Journal of Clinical Pharmacology. 52: 180-94. PMID 21233302 DOI: 10.1177/0091270010394851 |
0.075 |
|
| 2014 |
Welch-Reardon KM, Ehsan SM, Wang K, Wu N, Newman AC, Romero-Lopez M, Fong AH, George SC, Edwards RA, Hughes CC. Angiogenic sprouting is regulated by endothelial cell expression of Slug. Journal of Cell Science. 127: 2017-28. PMID 24554431 DOI: 10.1242/jcs.143420 |
0.075 |
|
| 2015 |
Singh BN, Dahiya D, Bagaria D, Saini V, Kaman L, Kaje V, Vagadiya A, Sarin S, Edwards R, Attri V, Jain K. Effects of preoperative carbohydrates drinks on immediate postoperative outcome after day care laparoscopic cholecystectomy. Surgical Endoscopy. PMID 25609319 DOI: 10.1007/S00464-015-4071-7 |
0.075 |
|
| 2015 |
Silva GG, Green KT, Dutilh BE, Edwards RA. SUPER-FOCUS: a tool for agile functional analysis of shotgun metagenomic data. Bioinformatics (Oxford, England). PMID 26454280 DOI: 10.1093/Bioinformatics/Btv584 |
0.075 |
|
| 2014 |
Tzoulis P, Evans R, Falinska A, Barnard M, Tan T, Woolman E, Leyland R, Martin N, Edwards R, Scott R, Gurazada K, Parsons M, Nair D, Khoo B, Bouloux PM. Multicentre study of investigation and management of inpatient hyponatraemia in the UK. Postgraduate Medical Journal. 90: 694-8. PMID 25398584 DOI: 10.1136/Postgradmedj-2014-132885 |
0.075 |
|
| 2007 |
Smaldone GM, Richard SD, Krivak TC, Kelley JL, Edwards RP. Pregnancy after tumor debulking and intraperitoneal cisplatin for appendiceal carcinoid tumor. Obstetrics and Gynecology. 110: 477-9. PMID 17666634 DOI: 10.1097/01.AOG.0000258785.00211.5d |
0.074 |
|
| 2015 |
Martel MO, Finan PH, Dolman AJ, Subramanian S, Edwards RR, Wasan AD, Jamison RN. Self-reports of medication side effects and pain-related activity interference in patients with chronic pain: a longitudinal cohort study. Pain. 156: 1092-100. PMID 25782367 DOI: 10.1097/J.Pain.0000000000000154 |
0.074 |
|
| 2014 |
Wideman TH, Finan PH, Edwards RR, Quartana PJ, Buenaver LF, Haythornthwaite JA, Smith MT. Increased sensitivity to physical activity among individuals with knee osteoarthritis: relation to pain outcomes, psychological factors, and responses to quantitative sensory testing. Pain. 155: 703-11. PMID 24378879 DOI: 10.1016/J.Pain.2013.12.028 |
0.074 |
|
| 2012 |
Campbell CM, Edwards RR. Ethnic differences in pain and pain management. Pain Management. 2: 219-230. PMID 23687518 DOI: 10.2217/Pmt.12.7 |
0.074 |
|
| 2014 |
Abraham M, Allen C, Bacon H, Dalzell F, Eastwood B, Edwards R, Elliott P, Fogle B, Hale G, Hale G, Jones M, Knight A, Lewis J, McGill I, MacMillan A, et al. Bovine TB and badger control. The Veterinary Record. 174: 664-6. PMID 24970635 DOI: 10.1136/Vr.G4232 |
0.074 |
|
| 2006 |
Zamboni WC, Friedland DM, Ramalingam S, Edwards RP, Stoller RG, Belani CP, Strychor S, Ou YC, Tonda ME, Ramanathan RK. Final results of a phase I and pharmacokinetic study of STEALTH liposomal CKD-602 (S-CKD602) in patients with advanced solid tumors Journal of Clinical Oncology. 24: 2013-2013. DOI: 10.1200/Jco.2006.24.18_Suppl.2013 |
0.074 |
|
| 2015 |
Coghlan ML, Maker G, Crighton E, Haile J, Murray DC, White NE, Byard RW, Bellgard MI, Mullaney I, Trengove R, Allcock RJ, Nash C, Hoban C, Jarrett K, Edwards R, et al. Combined DNA, toxicological and heavy metal analyses provides an auditing toolkit to improve pharmacovigilance of traditional Chinese medicine (TCM). Scientific Reports. 5: 17475. PMID 26658160 DOI: 10.1038/Srep17475 |
0.074 |
|
| 2015 |
Orr B, Lin J, Beriwal S, Edwards R, Kelley J, Olawaiye A, Comerci J, Huang M, Courtney-Brooks M, Sukumvanich P. Small cell neuroendocrine carcinoma of the cervix: Does treatment sequence and type of hysterectomy improve outcomes? Gynecologic Oncology. 137: 165. DOI: 10.1016/J.YGYNO.2015.01.412 |
0.074 |
|
| 1995 |
Bell MC, Edwards RP, Partridge EE, Kuykendall K, Conner W, Gore H, Turbat-Herrara E, Crowley-Nowick PA. CD8+ T lymphocytes are recruited to neoplastic cervix Journal of Clinical Immunology. 15: 130-136. PMID 7559915 DOI: 10.1007/BF01543104 |
0.074 |
|
| 2013 |
Altalibi M, Saltaji H, Edwards R, Major PW, Flores-Mir C. Indices to assess malocclusions in patients with cleft lip and palate. European Journal of Orthodontics. 35: 772-82. PMID 23504529 DOI: 10.1093/ejo/cjt009 |
0.074 |
|
| 2015 |
Lazaridou A, Edwards RR. Getting personal: The role of individual patient preferences and characteristics in shaping pain treatment outcomes. Pain. PMID 26447708 DOI: 10.1097/J.Pain.0000000000000376 |
0.073 |
|
| 2016 |
Adambekov S, Goughnour SL, Mansuria S, Donnellan N, Elishaev E, Villanueva HJ, Edwards RP, Bovbjerg DH, Linkov F. Patient and provider factors associated with endometrial Pipelle sampling failure. Gynecologic Oncology. PMID 27912906 DOI: 10.1016/J.Ygyno.2016.11.041 |
0.073 |
|
| 2015 |
Schneider C, Gordon ON, Edwards RL, Luis PB. Degradation of Curcumin: From Mechanism to Biological Implications. Journal of Agricultural and Food Chemistry. PMID 25817068 DOI: 10.1021/Acs.Jafc.5B00244 |
0.073 |
|
| 2014 |
Wiech K, Edwards R, Moseley GL, Berna C, Ploner M, Tracey I. Dissociable neural mechanisms underlying the modulation of pain and anxiety? An FMRI pilot study. Plos One. 9: e110654. PMID 25502237 DOI: 10.1371/Journal.Pone.0110654 |
0.073 |
|
| 2014 |
Jamison RN, Martel MO, Edwards RR, Qian J, Sheehan KA, Ross EL. Validation of a brief Opioid Compliance Checklist for patients with chronic pain. The Journal of Pain : Official Journal of the American Pain Society. 15: 1092-101. PMID 25092233 DOI: 10.1016/J.Jpain.2014.07.007 |
0.073 |
|
| 2017 |
Grabosch S, Boisen M, Ma T, Philips B, Strange M, Elishaev E, Tseng G, Edwards R, Taylor S, Huang M. Uterine leiomyosarcoma: Are novel therapeutics on the horizon? Gynecologic Oncology. 145: 89-90. DOI: 10.1016/J.YGYNO.2017.03.210 |
0.073 |
|
| 2015 |
Yue M, Han X, Masi LD, Zhu C, Ma X, Zhang J, Wu R, Schmieder R, Kaushik RS, Fraser GP, Zhao S, McDermott PF, Weill FX, Mainil JG, Arze C, ... Edwards RA, et al. Allelic variation contributes to bacterial host specificity. Nature Communications. 6: 8754. PMID 26515720 DOI: 10.1038/Ncomms9754 |
0.072 |
|
| 2015 |
Veerasamy M, Edwards R, Ford G, Kirkwood T, Newton J, Jones D, Kunadian V. Acute coronary syndrome among older patients: a review. Cardiology in Review. 23: 26-32. PMID 24407049 DOI: 10.1097/CRD.0000000000000016 |
0.072 |
|
| 2007 |
Spittle C, Ward MR, Nathanson KL, Gimotty PA, Rappaport E, Brose MS, Medina A, Letrero R, Herlyn M, Edwards RH. Application of a BRAF pyrosequencing assay for mutation detection and copy number analysis in malignant melanoma. The Journal of Molecular Diagnostics : Jmd. 9: 464-71. PMID 17690212 DOI: 10.2353/Jmoldx.2007.060191 |
0.072 |
|
| 2014 |
Kelly LW, Williams GJ, Barott KL, Carlson CA, Dinsdale EA, Edwards RA, Haas AF, Haynes M, Lim YW, McDole T, Nelson CE, Sala E, Sandin SA, Smith JE, Vermeij MJ, et al. Local genomic adaptation of coral reef-associated microbiomes to gradients of natural variability and anthropogenic stressors. Proceedings of the National Academy of Sciences of the United States of America. 111: 10227-32. PMID 24982156 DOI: 10.1073/Pnas.1403319111 |
0.072 |
|
| 2015 |
Fitzwater JL, Owen J, Ankumah NA, Campbell SB, Biggio JR, Szychowski JM, Edwards RK. Nulliparous Women in the Second Stage of Labor: Changes in Delivery Outcomes Between Two Cohorts From 2000 and 2011. Obstetrics and Gynecology. 126: 81-6. PMID 26241260 DOI: 10.1097/AOG.0000000000000872 |
0.072 |
|
| 2013 |
Badar A, Scaife J, Yan AT, Robinson SD, Zaman AG, Purcell IF, Ahmed JM, Egred M, Edwards RJ, Spyridopoulos I, Keavney BD, Bagnall AJ. Provision of gastroprotective medication and bleeding risk following acute coronary syndrome. The Journal of Invasive Cardiology. 25: 397-401. PMID 23913604 |
0.072 |
|
| 2009 |
Zamboni WC, Ramalingam S, Friedland DM, Edwards RP, Stoller RG, Strychor S, Maruca L, Zamboni BA, Belani CP, Ramanathan RK. Phase I and pharmacokinetic study of pegylated liposomal CKD-602 in patients with advanced malignancies. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 1466-72. PMID 19190127 DOI: 10.1158/1078-0432.Ccr-08-1405 |
0.071 |
|
| 2015 |
Rosenthal N, Meininger G, Ways K, Polidori D, Desai M, Qiu R, Alba M, Vercruysse F, Balis D, Shaw W, Edwards R, Bull S, Di Prospero N, Sha S, Rothenberg P, et al. Canagliflozin: a sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes mellitus. Annals of the New York Academy of Sciences. PMID 26305874 DOI: 10.1111/nyas.12852 |
0.071 |
|
| 2013 |
Bellet MM, Deriu E, Liu JZ, Grimaldi B, Blaschitz C, Zeller M, Edwards RA, Sahar S, Dandekar S, Baldi P, George MD, Raffatellu M, Sassone-Corsi P. Circadian clock regulates the host response to Salmonella. Proceedings of the National Academy of Sciences of the United States of America. 110: 9897-902. PMID 23716692 DOI: 10.1073/Pnas.1120636110 |
0.071 |
|
| 2015 |
Kim H, Kim J, Loggia ML, Cahalan C, Garcia RG, Vangel MG, Wasan AD, Edwards RR, Napadow V. Fibromyalgia is characterized by altered frontal and cerebellar structural covariance brain networks. Neuroimage. Clinical. 7: 667-77. PMID 25844321 DOI: 10.1016/J.Nicl.2015.02.022 |
0.071 |
|
| 2013 |
Dutilh BE, Backus L, Edwards RA, Wels M, Bayjanov JR, van Hijum SA. Explaining microbial phenotypes on a genomic scale: GWAS for microbes. Briefings in Functional Genomics. 12: 366-80. PMID 23625995 DOI: 10.1093/Bfgp/Elt008 |
0.071 |
|
| 2015 |
Bradford NK, Edwards RM, Chan RJ. Heparin versus 0.9% sodium chloride intermittent flushing for the prevention of occlusion in long term central venous catheters in infants and children. The Cochrane Database of Systematic Reviews. 11: CD010996. PMID 26590504 DOI: 10.1002/14651858.CD010996.pub2 |
0.071 |
|
| 2013 |
Okoturo-Evans O, Dybowska A, Valsami-Jones E, Cupitt J, Gierula M, Boobis AR, Edwards RJ. Elucidation of toxicity pathways in lung epithelial cells induced by silicon dioxide nanoparticles. Plos One. 8: e72363. PMID 24023737 DOI: 10.1371/journal.pone.0072363 |
0.071 |
|
| 2015 |
Low YS, Caster O, Bergvall T, Fourches D, Zang X, Norén GN, Rusyn I, Edwards R, Tropsha A. Cheminformatics-aided pharmacovigilance: application to Stevens-Johnson Syndrome. Journal of the American Medical Informatics Association : Jamia. PMID 26499102 DOI: 10.1093/Jamia/Ocv127 |
0.071 |
|
| 2015 |
Loggia ML, Berna C, Kim J, Cahalan CM, Martel MO, Gollub RL, Wasan AD, Napadow V, Edwards RR. The Lateral Prefrontal Cortex Mediates the Hyperalgesic Effects of Negative Cognitions in Chronic Pain Patients. The Journal of Pain : Official Journal of the American Pain Society. PMID 25937162 DOI: 10.1016/J.Jpain.2015.04.003 |
0.07 |
|
| 2014 |
Silva GG, Cuevas DA, Dutilh BE, Edwards RA. FOCUS: an alignment-free model to identify organisms in metagenomes using non-negative least squares. Peerj. 2: e425. PMID 24949242 DOI: 10.7717/Peerj.425 |
0.07 |
|
| 2014 |
Edwards RK, Reed CA, Villano KS, Holmes JL, Tong S, Davies JK. Effect of hydration on spontaneous labor outcomes in nulliparous pregnant women: a multicenter randomized controlled trial comparing three methods. American Journal of Perinatology. 31: 455-62. PMID 23884718 DOI: 10.1055/s-0033-1351661 |
0.07 |
|
| 2015 |
Martinson EO, Martinson VG, Edwards R, Mrinalini, Werren JH. Laterally transferred gene recruited as a venom in parasitoid wasps. Molecular Biology and Evolution. PMID 26715630 DOI: 10.1093/Molbev/Msv348 |
0.069 |
|
| 2015 |
Gittins JR, D'Angelo C, Oswald F, Edwards RJ, Wiedenmann J. Fluorescent protein-mediated colour polymorphism in reef corals: multicopy genes extend the adaptation/acclimatization potential to variable light environments. Molecular Ecology. 24: 453-65. PMID 25496144 DOI: 10.1111/Mec.13041 |
0.069 |
|
| 2013 |
Edwards RM, Chapman T, Horn DL, Paladin AM, Iyer RS. Imaging of pediatric floor of mouth lesions. Pediatric Radiology. 43: 523-35. PMID 23429804 DOI: 10.1007/s00247-013-2620-6 |
0.069 |
|
| 2014 |
Edwards RD, Mason CN. Spinning the wheels and rolling the dice: life-cycle risks and benefits of bicycle commuting in the U.S. Preventive Medicine. 64: 8-13. PMID 24657549 DOI: 10.1016/J.Ypmed.2014.03.015 |
0.069 |
|
| 2014 |
Luiza JW, Taylor SE, Gao FF, Edwards RP. Placental site trophoblastic tumor: Immunohistochemistry algorithm key to diagnosis and review of literature. Gynecologic Oncology Case Reports. 7: 13-5. PMID 24624322 DOI: 10.1016/j.gynor.2013.11.001 |
0.069 |
|
| 2015 |
Abramovici A, Lobashevsky E, Cliver SP, Edwards RK, Hauth JC, Biggio JR. Quantitative Polymerase Chain Reaction to Assess Response to Treatment of Bacterial Vaginosis and Risk of Preterm Birth. American Journal of Perinatology. PMID 26023904 DOI: 10.1055/s-0035-1549294 |
0.068 |
|
| 2015 |
Smith SM, Paillard F, McKeown A, Burke LB, Edwards RR, Katz NP, Papadopoulos EJ, Rappaport BA, Slagle A, Strain EC, Wasan AD, Turk DC, Dworkin RH. Instruments to Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: An ACTTION Systematic Review. The Journal of Pain : Official Journal of the American Pain Society. 16: 389-411. PMID 25660826 DOI: 10.1016/J.Jpain.2015.01.009 |
0.068 |
|
| 2014 |
Busse M, Quinn L, Dawes H, Jones C, Kelson M, Poile V, Trubey R, Townson J, Edwards RT, Rosser A, Hood K. Supporting physical activity engagement in people with Huntington's disease (ENGAGE-HD): study protocol for a randomized controlled feasibility trial. Trials. 15: 487. PMID 25494622 DOI: 10.1186/1745-6215-15-487 |
0.068 |
|
| 1991 |
Szarewski A, Cuzick J, Edwards R, Butler B, Singer A. The use of cervicography in a primary screening service. British Journal of Obstetrics and Gynaecology. 98: 313-7. PMID 2021571 DOI: 10.1111/j.1471-0528.1991.tb13400.x |
0.068 |
|
| 2015 |
Liu W, Martinón-Torres M, Cai YJ, Xing S, Tong HW, Pei SW, Sier MJ, Wu XH, Edwards RL, Cheng H, Li YY, Yang XX, de Castro JM, Wu XJ. The earliest unequivocally modern humans in southern China. Nature. PMID 26466566 DOI: 10.1038/nature15696 |
0.068 |
|
| 2017 |
Downs-Canner S, Berkey S, Delgoffe GM, Edwards RP, Curiel T, Odunsi K, Bartlett DL, Obermajer N. Suppressive IL-17A(+)Foxp3(+) and ex-Th17 IL-17A(neg)Foxp3(+) Treg cells are a source of tumour-associated Treg cells. Nature Communications. 8: 14649. PMID 28290453 DOI: 10.1038/Ncomms14649 |
0.068 |
|
| 2013 |
Belfer I, Segall SK, Lariviere WR, Smith SB, Dai F, Slade GD, Rashid NU, Mogil JS, Campbell CM, Edwards RR, Liu Q, Bair E, Maixner W, Diatchenko L. Pain modality- and sex-specific effects of COMT genetic functional variants. Pain. 154: 1368-76. PMID 23701723 DOI: 10.1016/J.Pain.2013.04.028 |
0.068 |
|
| 2012 |
Wu H, Ramanathan RK, Zamboni BA, Strychor S, Ramalingam S, Edwards RP, Friedland DM, Stoller RG, Belani CP, Maruca LJ, Bang YJ, Zamboni WC. Mechanism-based model characterizing bidirectional interaction between PEGylated liposomal CKD-602 (S-CKD602) and monocytes in cancer patients. International Journal of Nanomedicine. 7: 5555-64. PMID 23112576 DOI: 10.2147/Ijn.S35751 |
0.068 |
|
| 2015 |
Bartolomé M, Moreno A, Sancho C, Stoll HM, Cacho I, Spötl C, Belmonte Á, Edwards RL, Cheng H, Hellstrom JC. Hydrological change in Southern Europe responding to increasing North Atlantic overturning during Greenland Stadial 1. Proceedings of the National Academy of Sciences of the United States of America. 112: 6568-72. PMID 25964366 DOI: 10.1073/pnas.1503990112 |
0.068 |
|
| 2021 |
Prince EA, Sanzari JK, Pandya D, Huron D, Edwards R. Analytical Concordance of PD-L1 Assays Utilizing Antibodies From FDA-Approved Diagnostics in Advanced Cancers: A Systematic Literature Review. Jco Precision Oncology. 5: 953-973. PMID 34136742 DOI: 10.1200/PO.20.00412 |
0.067 |
|
| 2015 |
Tan L, Cai Y, An Z, Cheng H, Shen CC, Breitenbach SF, Gao Y, Edwards RL, Zhang H, Du Y. A Chinese cave links climate change, social impacts, and human adaptation over the last 500 years. Scientific Reports. 5: 12284. PMID 26270656 DOI: 10.1038/srep12284 |
0.067 |
|
| 2013 |
Taylor VL, Cummins I, Brazier-Hicks M, Edwards R. Protective responses induced by herbicide safeners in wheat. Environmental and Experimental Botany. 88: 93-99. PMID 23564986 DOI: 10.1016/J.Envexpbot.2011.12.030 |
0.067 |
|
| 1997 |
Faul C, Miramow D, Gerszten K, Haung C, Edwards R. Isolated local recurrence in carcinoma of the vulva: Prognosis and implications for treatment European Journal of Cancer. 33: S205. DOI: 10.1016/S0959-8049(97)85650-X |
0.067 |
|
| 2015 |
Edwards RK, Szychowski JM, Bodea-Braescu AV, Biggio JR, Lin MG. Foley catheter for induction of labor: potential barriers to adopting the technique. Journal of Perinatology : Official Journal of the California Perinatal Association. PMID 26468934 DOI: 10.1038/jp.2015.123 |
0.067 |
|
| 1994 |
Alvarez RD, Helm CW, Edwards RP, Naumann RW, Partridge EE, Shingleton HM, McGee JA, Hall JR, Higgins RV, Malone JM. Prospective Randomized Trial of LLETZ Versus Laser Ablation in Patients With Cervical Intraepithelial Neoplasia Obstetrical & Gynecological Survey. 49: 403-404. DOI: 10.1097/00006254-199406000-00017 |
0.067 |
|
| 2014 |
Martel MO, Dolman AJ, Edwards RR, Jamison RN, Wasan AD. The association between negative affect and prescription opioid misuse in patients with chronic pain: the mediating role of opioid craving. The Journal of Pain : Official Journal of the American Pain Society. 15: 90-100. PMID 24295876 DOI: 10.1016/J.Jpain.2013.09.014 |
0.067 |
|
| 2014 |
Austin D, Yan AT, Spratt JC, Kunadian V, Edwards RJ, Egred M, Bagnall AJ. Patient characteristics associated with self-presentation, treatment delay and survival following primary percutaneous coronary intervention. European Heart Journal. Acute Cardiovascular Care. 3: 214-22. PMID 24619818 DOI: 10.1177/2048872614527011 |
0.067 |
|
| 2015 |
Pine C, Adair P, Burnside G, Robinson L, Edwards RT, Albadri S, Curnow M, Ghahreman M, Henderson M, Malies C, Wong F, Muirhead V, Weston-Price S, Whitehead H. A new primary dental care service compared with standard care for child and family to reduce the re-occurrence of childhood dental caries (Dental RECUR): study protocol for a randomised controlled trial. Trials. 16: 505. PMID 26537725 DOI: 10.1186/s13063-015-1010-9 |
0.067 |
|
| 2012 |
Qian F, Liao J, Villella J, Edwards R, Kalinski P, Lele S, Shrikant P, Odunsi K. Effects of 1-methyltryptophan stereoisomers on IDO2 enzyme activity and IDO2-mediated arrest of human T cell proliferation. Cancer Immunology, Immunotherapy : Cii. 61: 2013-20. PMID 22527253 DOI: 10.1007/S00262-012-1265-X |
0.067 |
|
| 2007 |
Zamboni W, Maruca LJ, Strychor S, Zamboni BA, Ramalingam S, Edwards RP, Friedland DM, Stoller RG, Belani CP, Ramanathan RK. Age and body composition related-effects on the pharmacokinetic disposition of STEALTH liposomal CKD- 602 (S-CKD602) in patients with advanced solid tumors Journal of Clinical Oncology. 25: 2528-2528. DOI: 10.1200/Jco.2007.25.18_Suppl.2528 |
0.067 |
|
| 2015 |
Edwards RT, Yeo ST, Russell D, Thomson CE, Beggs I, Gibson JN, McMillan D, Martin DJ, Russell IT. Cost-effectiveness of steroid (methylprednisolone) injections versus anaesthetic alone for the treatment of Morton's neuroma: economic evaluation alongside a randomised controlled trial (MortISE trial). Journal of Foot and Ankle Research. 8: 6. PMID 25737743 DOI: 10.1186/s13047-015-0064-y |
0.067 |
|
| 2018 |
Dohopolski M, Horne Z, Pradhan D, Bhargava R, Edwards R, Kelley J, Comerci J, Olawaiye A, Courtney-Brooks M, Boisen M, Berger J, Taylor S, Sukumvanich P, Beriwal S. Adjuvant Radiation Therapy for Vulvar Squamous Cell Carcinoma: Does p16-Positivity Influence Locoregional Control? International Journal of Radiation Oncology*Biology*Physics. 102: e657-e658. DOI: 10.1016/j.ijrobp.2018.07.1782 |
0.066 |
|
| 2014 |
Littlejohn M, Davies J, Yuen L, Edwards R, Sozzi T, Jackson K, Cowie B, Tong S, Davis J, Locarnini S. Molecular virology of hepatitis B virus, sub-genotype C4 in northern Australian Indigenous populations. Journal of Medical Virology. 86: 695-706. PMID 24497078 DOI: 10.1002/jmv.23888 |
0.066 |
|
| 1976 |
Edwards RP, Balfour RP. The clinical diagnosis of major congenital abnormalities of the fetal central nervous system. British Journal of Obstetrics and Gynaecology. 83: 422-4. PMID 776207 DOI: 10.1111/j.1471-0528.1976.tb00857.x |
0.066 |
|
| 2014 |
Fillingim RB, Bruehl S, Dworkin RH, Dworkin SF, Loeser JD, Turk DC, Widerstrom-Noga E, Arnold L, Bennett R, Edwards RR, Freeman R, Gewandter J, Hertz S, Hochberg M, Krane E, et al. The ACTTION-American Pain Society Pain Taxonomy (AAPT): an evidence-based and multidimensional approach to classifying chronic pain conditions. The Journal of Pain : Official Journal of the American Pain Society. 15: 241-9. PMID 24581634 DOI: 10.1016/J.Jpain.2014.01.004 |
0.066 |
|
| 2014 |
Wilson MS, Ingersoll M, Meschter E, Bodea-Braescu AV, Edwards RK. Evaluating the side effects of treatment for preterm labor in a center that uses "high-dose" magnesium sulfate. American Journal of Perinatology. 31: 711-6. PMID 24338122 DOI: 10.1055/s-0033-1358770 |
0.066 |
|
| 2013 |
Colwell CM, Edwards R, Hernandez E, Brees K. Impact of music therapy interventions (listening, composition, Orff-based) on the physiological and psychosocial behaviors of hospitalized children: a feasibility study. Journal of Pediatric Nursing. 28: 249-57. PMID 23036597 DOI: 10.1016/j.pedn.2012.08.008 |
0.066 |
|
| 1997 |
Crowley-Nowick PA, Bell MC, Brockwell R, Edwards RP, Chen S, Partridge EE, Mestecky J. Rectal immunization for induction of specific antibody in the genital tract of women Journal of Clinical Immunology. 17: 370-379. PMID 9327336 DOI: 10.1023/A:1027312223474 |
0.066 |
|
| 2014 |
Whitaker R, Hendry M, Booth A, Carter B, Charles J, Craine N, Edwards RT, Lyons M, Noyes J, Pasterfield D, Rycroft-Malone J, Williams N. Intervention Now To Eliminate Repeat Unintended Pregnancy in Teenagers (INTERUPT): a systematic review of intervention effectiveness and cost-effectiveness, qualitative and realist synthesis of implementation factors and user engagement. Bmj Open. 4: e004733. PMID 24722200 DOI: 10.1136/bmjopen-2013-004733 |
0.066 |
|
| 2002 |
Castle PE, Hildesheim A, Bowman FP, Strickler HD, Walker JL, Pustilnik T, Edwards RP, Crowley-Nowick PA. Cervical concentrations of interleukin-10 and interleukin-12 do not correlate with plasma levels Journal of Clinical Immunology. 22: 23-27. PMID 11958590 DOI: 10.1023/A:1014252402630 |
0.066 |
|
| 2014 |
Mountain GA, Hind D, Gossage-Worrall R, Walters SJ, Duncan R, Newbould L, Rex S, Jones C, Bowling A, Cattan M, Cairns A, Cooper C, Edwards RT, Goyder EC. 'Putting Life in Years' (PLINY) telephone friendship groups research study: pilot randomised controlled trial. Trials. 15: 141. PMID 24758530 DOI: 10.1186/1745-6215-15-141 |
0.065 |
|
| 2014 |
Dolman AJ, Loggia ML, Edwards RR, Gollub RL, Kong J, Napadow V, Wasan AD. Phenotype matters: the absence of a positive association between cortical thinning and chronic low back pain when controlling for salient clinical variables. The Clinical Journal of Pain. 30: 839-45. PMID 24135900 DOI: 10.1097/Ajp.0000000000000043 |
0.065 |
|
| 2012 |
Gamblin T, Alexander H, Edwards R, Bartlett DL. Concepts of regional therapies for advanced malignancy. Annals of Surgical Oncology. 19: 1371-2. PMID 22302272 DOI: 10.1245/s10434-012-2243-4 |
0.065 |
|
| 2015 |
Sanei-Moghaddam A, Ma T, Goughnour SL, Edwards RP, Lounder PJ, Ismail N, Comerci JT, Mansuria SM, Linkov F. Changes in Hysterectomy Trends After the Implementation of a Clinical Pathway. Obstetrics and Gynecology. PMID 26646126 DOI: 10.1097/AOG.0000000000001185 |
0.065 |
|
| 2014 |
Rahimi F, Bee C, Duval C, Boissy P, Edwards R, Jog M. Using ecological whole body kinematics to evaluate effects of medication adjustment in Parkinson disease. Journal of Parkinson's Disease. 4: 617-27. PMID 25055960 DOI: 10.3233/Jpd-140370 |
0.065 |
|
| Hide low-probability matches. |